Processing 00000000.tx.1: Sequences from the Low Density Lipoprotein Receptor-related Protein (LRP) Cytoplasmic Domain Enhance Amyloid Protein Production via the -Secretase Pathway without Altering Amyloid Precursor Protein/LRP Nuclear Signaling* Il-Sang Yoon, Claus U. 

Phrase: "Sequences from the Low Density Lipoprotein Receptor-related Protein (LRP) Cytoplasmic Domain"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   754   C0002518:protein sequences [Amino Acid Sequence]
   738   C0162326:Sequences [Nucleotide Sequence]
   704 E C0004793:Sequence [Nucleotide Sequence]
   704 E C0162327:Sequence [Nucleotide Sequence]
   704 E C1519249:Sequence [Functional Concept]

Phrase: "Enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "Amyloid Protein Production via the -Secretase Pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033268:production [Occupational Activity]

Phrase: "without Altering Amyloid Precursor Protein/LRP Nuclear Signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C1514762:Receptor Signaling [Molecular Function]
   790   C0037083:Signaling [Cell Function]
   790   C3537152:signaling [Biologic Function]

Phrase: "* Il-Sang Yoon,"

Phrase: "Claus U."
Processing 00000000.tx.2: Pietrzik, David E. 

Phrase: "Pietrzik,"

Phrase: "David E."
Processing 00000000.tx.3: Kang, and Edward H. 

Phrase: "Kang,"

Phrase: "and"

Phrase: "Edward H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: Koo From the Department of Neurosciences, University of California, San Diego, La Jolla, California 92093 Received for publication, December 6, 2004 , and in revised form, March 15, 2005.  

Phrase: "Koo From the Department of Neurosciences,"

Phrase: "University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "California 92093"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006754:California [Geographic Area]
   861   C3146274:California [Plant]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "December 6,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "March 15,"

Phrase: "2005."
Processing 00000000.tx.5: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Increasing evidence suggests that the low density lipoprotein receptor-related protein (LRP) affects the processing of amyloid precursor protein (APP) and amyloid (A) protein production as well as mediates the clearance of A from the brain. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "(LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the processing of amyloid precursor protein (APP)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "amyloid (A) protein production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033268:production [Occupational Activity]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the clearance of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.6: Recent studies indicate that the cytoplasmic domain of LRP is critical for this modulation of APP processing requiring perhaps a complex between APP, the adaptor protein FE65, and LRP. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cytoplasmic domain of LRP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1511625:Cytoplasmic Domain [Cell Component]
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "critical for this modulation of APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1511545:Critical [Qualitative Concept]

Phrase: "requiring"

Phrase: "perhaps"

Phrase: "a complex between APP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1523872:protein complex [Cell Component]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "the adaptor protein FE65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412459:FE65 [Gene or Genome]
   734   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "LRP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: In this study, we expressed a small LRP domain consisting of the C-terminal 97 amino acids of the cytoplasmic domain, or LRP-soluble tail (LRP-ST), in CHO cells to test the hypothesis that the APPLRP complex can be disrupted. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "expressed"

Phrase: "a small LRP domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0162808:Protein Domain [Spatial Concept]
   827   C1514562:Protein Domain [Amino Acid Sequence]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "consisting of the C-terminal 97 amino acids of the cytoplasmic domain,"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   767   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
           C-Terminal
   753   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1511625:Cytoplasmic Domain [Cell Component]
   736   C0001128:Acids [Chemical]
   736   C0010834:Cytoplasmic [Cell Component]
   736   C0205088:Terminal [Temporal Concept]
   736   C0439073:97 [Intellectual Product]
   736   C0439082:>97 [Quantitative Concept]
   736   C0521449:Cytoplasmic [Body Location or Region]
   736   C1705314:Terminal [Manufactured Object]
   736   C1705315:Terminal [Spatial Concept]
   736   C1880389:Domain [Functional Concept]
   736   C1883221:Domain [Conceptual Entity]
   736   C3541951:Domain [Intellectual Product]
   719 E C2917660:Amino Acid [Pharmacologic Substance]
   703 E C0202406:Acid [Laboratory Procedure]
   703   C0332529:CONSIST [Qualitative Concept]

Phrase: "or"

Phrase: "LRP-soluble tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0039259:Tail [Body Part, Organ, or Organ Component]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "(LRP-ST),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "in CHO cells to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0085080:CHO Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the APPLRP complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "can"

Phrase: "be"

Phrase: "disrupted."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]
Processing 00000000.tx.8: We anticipated that LRP-ST would inhibit the normal interaction between LRP and APP and therefore perturb APP processing to resemble a LRP-deficient state. 

Phrase: "We"

Phrase: "anticipated"

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "would"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the normal interaction between LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0872079:interaction protein [Molecular Function]
   744   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "therefore"

Phrase: "perturb"

Phrase: "APP processing to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "resemble"

Phrase: "a LRP-deficient state."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C1301808:State [Geographic Area]
   799   C1442792:State [Functional Concept]
   799   C3148680:State [Geographic Area]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.9: Surprisingly, CHO cells expressing LRP-ST demonstrated an increase in both sAPP secretion and A production compared with control CHO cells in a manner reminiscent of the cellular effects of the APP "Swedish mutation." 

Phrase: "Surprisingly,"

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "demonstrated"

Phrase: "an increase in both sAPP secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "compared with control CHO cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0085080:CHO Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in a manner"

Phrase: "reminiscent of the cellular effects"

Phrase: "of the APP ""Swedish mutation."""
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.10: The increase in sAPP secretion consisted mainly of sAPP, consistent with the increase in A release. 

Phrase: "The increase in sAPP secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "consisted"

Phrase: "mainly of sAPP,"

Phrase: "consistent with the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in A release."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
Processing 00000000.tx.11: Further, this effect is LRP-independent, as the same alterations remained when LRP-ST was expressed in LRP-deficient cells but not when the construct was membrane-anchored. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "LRP-independent,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0085862:Independent [Idea or Concept]
   804   C1299583:Independent [Finding]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "as"

Phrase: "the same alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "remained"

Phrase: "when"

Phrase: "LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "expressed in LRP-deficient cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   750   C1514760:Receptor Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0011155:Deficient [Functional Concept]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1636779:% deficient [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "the construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "membrane-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "anchored."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1293132:anchored [Therapeutic or Preventive Procedure]
Processing 00000000.tx.12: Finally, deletion experiments suggested that the last 50 amino acid residues of LRP-ST contain the important domain for altering APP processing and A production. 

Phrase: "Finally,"

Phrase: "deletion experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the last 50 amino acid residues of LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the important domain for altering APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.13: These observations indicate that there are cellular pathways that may suppress A generation but that can be altered to facilitate A production.  

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that there"

Phrase: "are"

Phrase: "cellular pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "may"

Phrase: "suppress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "but"

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "facilitate"

Phrase: "A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.14: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The low density lipoprotein receptor-related protein (LRP)1 is a large type I transmembrane protein that functions as a multifunctional endocytosis receptor for a diverse array of extracellular ligands (1, 2). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "(LRP)1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   840   C0087044:protein i [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a large type I transmembrane protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0021699:Transmembrane protein [Amino Acid, Peptide, or Protein]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1167322:transmembrane [Cell Component]
   804   C2752508:transmembrane [Cell Component]

Phrase: "that functions as a multifunctional endocytosis receptor"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0920644:function receptor [Molecular Function]
   748   C0542341:Functions [Functional Concept]
   714 E C0031843:function [Physiologic Function]
   714 E C0700205:FUNCTION [Classification]
   714 E C1705273:Function [Intellectual Product]

Phrase: "for a diverse array"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510941:Array [Spatial Concept]

Phrase: "of extracellular ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: LRP is synthesized as a 600-kDa precursor protein that is subsequently cleaved in the trans-Golgi compartment by furin to generate a large 515-kDa -chain and a smaller 85-kDa membrane-associated -chain that remain non-covalently linked (3, 4). 

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "synthesized as a 600-kDa precursor protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1532717:kDa [Quantitative Concept]
   748   C1709634:Precursor [Idea or Concept]
   748   C1883254:Synthesized [Activity]

Phrase: "that"

Phrase: "is"

Phrase: "subsequently"

Phrase: "cleaved in the trans-Golgi compartment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018042:Golgi [Cell Component]
   753   C0205242:Cleaved [Spatial Concept]
   753   C0333853:Cleaved [Cell]
   753   C1185625:Compartment [Body Space or Junction]
   753   C2826298:TRANS [Idea or Concept]
   753   C2986730:Compartment [Spatial Concept]

Phrase: "by furin to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919550:FURIN [Gene or Genome]

Phrase: "generate"

Phrase: "a large 515-kDa -chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "a smaller 85-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "membrane-associated -"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0332281:Associated [Qualitative Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337112:Chain [Manufactured Object]
  1000   C1524075:Chain [Idea or Concept]

Phrase: "that"

Phrase: "remain"

Phrase: "non-covalently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Non [Functional Concept]

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.16: The cytoplasmic tail contains two NPXY endocytosis motifs and binds a number of cytoplasmic adaptor and scaffold proteins, such as FE65, Mint2, Disabled-1 (Dab1), Shc, and JIP-1 and -2, probably through the second NPXY motif (57). 

Phrase: "The cytoplasmic tail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1511625:Cytoplasmic Tail [Cell Component]
   861   C0010834:Cytoplasmic [Cell Component]
   861   C0039259:Tail [Body Part, Organ, or Organ Component]
   861   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two NPXY endocytosis motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1514562:Motif [Amino Acid Sequence]

Phrase: "and"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "a number of cytoplasmic adaptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "scaffold proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179132:Scaffold protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as FE65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "Mint2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412457:MINT2 [Gene or Genome]
  1000   C3538727:MINT2 [Gene or Genome]

Phrase: "Disabled-1 (Dab1),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018576:Disabled [Patient or Disabled Group]
   861   C1880351:Disabled [Qualitative Concept]

Phrase: "Shc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705297:SHC [Gene or Genome]

Phrase: "and"

Phrase: "JIP-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417024:JIP-1 [Gene or Genome]
   861   C0345893:JIP [Neoplastic Process]

Phrase: "and -"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "probably through the second NPXY motif"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205436:Second [Quantitative Concept]
   753   C0457385:Second [Temporal Concept]
   753   C0565930:/second [Quantitative Concept]
   753   C0750492:Probably [Idea or Concept]
   753   C1514562:Motif [Amino Acid Sequence]
   753   C1561503:second [Idea or Concept]
   753   C1705190:Second [Qualitative Concept]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.17: In addition, LRP itself undergoes a presenilin-dependent -secretase intramembrane proteolysis, releasing a potentially transcriptionally active fragment in a manner similar to APP and Notch (8, 9). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself"

Phrase: "undergoes"

Phrase: "a presenilin-dependent -secretase intramembrane proteolysis,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C2987018:Intramembrane Proteolysis [Phenomenon or Process]
   804   C0597304:Proteolysis [Molecular Function]
   733 E C1947941:proteolytic [Enzyme]

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a potentially transcriptionally active fragment in a manner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "similar to APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "(8,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.18: Recent studies have implicated a role for the LRP pathway in Alzheimer disease pathogenesis. 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "implicated"

Phrase: "a role for the LRP pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer disease pathogenesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0543483:pathogenesis [Functional Concept]
   827   C0699748:Pathogenesis [Pathologic Function]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.19: LRP and three of its key ligands, apoE, 2-macroglobulin, and APP, are genetically associated with Alzheimer disease and are found in senile plaques in the brains of Alzheimer disease patients (1013). 

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "three of its key ligands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0023688:Ligands [Chemical]
   760   C0205449:Three [Quantitative Concept]

Phrase: "apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "2-macroglobulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "are"

Phrase: "genetically"

Phrase: "associated with Alzheimer disease"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "are"

Phrase: "found in senile plaques"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   770   C0150312:Found [Quantitative Concept]
   770   C0392079:Senile [Finding]
   737 E C0011389:Plaque [Disease or Syndrome]
   737 E C0243095:Find [Finding]
   737 E C0332461:Plaque [Finding]
   715 E C0231337:Old age [Finding]
   715 E C1999167:Old age [Population Group]

Phrase: "in the brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006104:Brains [Body Part, Organ, or Organ Component]
   966 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of Alzheimer disease patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "(1013"

Phrase: ")."
Processing 00000000.tx.20: LRP also mediates the binding and clearance of amyloid peptide (A) complexes bound to apoE or 2-macroglobulin in cultured cells and in the brain (1416). 

Phrase: "LRP also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "clearance of amyloid peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0449297:Clearance [Qualitative Concept]
   770   C1382187:Clearance [Clinical Attribute]
   770   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "(A"

Phrase: ")"

Phrase: "complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "bound to apoE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332297:bound [Spatial Concept]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1412481:APOE [Gene or Genome]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "or"

Phrase: "2-macroglobulin in cultured cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and in the brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]

Phrase: "(1416"

Phrase: ")."
Processing 00000000.tx.21: In addition, LRP may play a crucial role in brain efflux of A isoforms at the blood-brain barrier (17, 18). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in brain efflux of A isoforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "at the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.22: These findings therefore support a model in which LRP plays an important role in A uptake and removal. 

Phrase: "These findings therefore"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a model in which LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C3161035:Model [Intellectual Product]
   717   C0814053:relational model [Mental Process]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in A uptake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "removal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015252:Removal [Therapeutic or Preventive Procedure]
  1000   C0728940:Removal [Therapeutic or Preventive Procedure]
Processing 00000000.tx.23: In a dual but opposing effect, it has been proposed that LRP can also promote A production by altering the trafficking and processing of APP, possibly by APP/LRP interactions via the Kunitz protease inhibitor domain as well as through cytoplasmic adaptor proteins (7, 1923). 

Phrase: "In a dual"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554184:Dual [Intellectual Product]

Phrase: "but"

Phrase: "opposing effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "also"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "A production by altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "the"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "processing of APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0033666:protein processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "possibly by APP/LRP interactions"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   799   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   766   C0872079:Protein-Protein Interaction [Molecular Function]
           interactions protein
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   757   C1372999:Receptor Interactions [Molecular Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1705910:Possibly Related [Qualitative Concept]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   739   C2362652:Possibly [Qualitative Concept]
   706   C1704675:Interaction [Functional Concept]

Phrase: "via the Kunitz protease inhibitor domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1514524:Protease Domain [Amino Acid Sequence]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "as well as through cytoplasmic adaptor proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   762   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205170:Well [Qualitative Concept]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C1706710:Adaptor [Manufactured Object]
   748   C3146287:Well [Manufactured Object]

Phrase: "(7,"

Phrase: "1923"

Phrase: ")."
Processing 00000000.tx.24: Absence of LRP or treatment of receptor-associated protein, an antagonist of all known LRP ligands, substantially reduced A release, a phenotype that was reversed when full-length or truncated LRP was transfected in LRP-deficient cells (20, 21). 

Phrase: "Absence of LRP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0680208:absence of relation [Social Behavior]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   716   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "or"

Phrase: "treatment of receptor-associated protein,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "an antagonist of all known LRP ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0231491:Antagonist [Organ or Tissue Function]

Phrase: "substantially reduced A release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "that"

Phrase: "was"

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "when"

Phrase: "full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "or"

Phrase: "truncated LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "transfected in LRP-deficient cells"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   750   C1514760:Receptor Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0011155:Deficient [Functional Concept]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1636779:% deficient [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(20,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.25: The domain in LRP that is responsible for regulating APP processing and A production was mapped to the cytosolic tail; 

Phrase: "The domain in LRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0162808:Protein Domain [Spatial Concept]
   774   C1514562:Protein Domain [Amino Acid Sequence]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "responsible for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1273518:Responsible [Finding]

Phrase: "regulating"

Phrase: "APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "mapped to the cytosolic tail"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C1383501:Cytosolic [Cell Component]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.26: specifically, a seven-amino acid motif that included the distal NPVY site (20). 

Phrase: "specifically,"

Phrase: "a seven-amino acid motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C0752190:Motif, Amino Acid [Spatial Concept]
   812   C1514562:Motif [Amino Acid Sequence]

Phrase: "that"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the distal NPVY site"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0449639:Distal site [Spatial Concept]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.27: These results suggested that the cytoplasmic domain of LRP plays a major role in APP processing. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the cytoplasmic domain of LRP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1511625:Cytoplasmic Domain [Cell Component]
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role in APP processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.28: We hypothesized that formation of a LRPAPP complex is important for normal APP processing and have shown that indeed, APP and LRP appear to be functionally linked by the adaptor protein FE65 (24). 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that formation of a LRPAPP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "important for normal APP processing"

Phrase: "and"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that indeed,"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "functionally"

Phrase: "linked by the adaptor protein FE65"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1412459:FE65 [Gene or Genome]
   753   C1706710:Adaptor [Manufactured Object]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.29: In this study, we tested the idea that blocking the interaction between LRP and APP could reduce A production in a manner similar to that observed in LRP-deficient cells. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the interaction between LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "could"

Phrase: "reduce"

Phrase: "A production in a manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "observed in LRP-deficient cells."
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   750   C1514760:Receptor Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0011155:Deficient [Functional Concept]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1441672:Observed [Functional Concept]
   744   C1636779:% deficient [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.30: We hypothesized that expression of a LRP construct, consisting of only the last 97 amino acid residues of the cytosolic tail of LRP, will block LRP/APP interaction and, in so doing, alter APP processing and A generation. 

Phrase: "We"

Phrase: "hypothesized"

Phrase: "that expression of a LRP construct,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0597360:receptor expression [Genetic Function]
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "consisting of only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "the last 97 amino acid residues of the cytosolic tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "of LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "will"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "LRP/APP interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   855   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   793   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: ","

Phrase: "in so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "doing"

Phrase: ","

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "A generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.31: Surprisingly, expression of the soluble LRP cytosolic fragment did not impair A production as expected. 

Phrase: "Surprisingly,"

Phrase: "expression of the soluble LRP cytosolic fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "A production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "expected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.32: Instead this fragment altered APP processing by positively regulating the -secretase pathway of APP cleavage.  

Phrase: "Instead"

Phrase: "this fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "APP processing by positively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "regulating"

Phrase: "the -secretase pathway of APP cleavage."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.33: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  cDNA ConstructsThe mutant LRP constructs used in this study are schematically illustrated in Fig. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "cDNA ConstructsThe mutant LRP constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827421:Construct [Classification]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: "schematically"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.34: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.35: The Myc-tagged last 97 amino acids of the cytoplasmic region of the LRP -subunit (Myc-LRP-ST) and various LRP derivates were generated by PCR. 

Phrase: "The Myc-tagged last 97 amino acids of the cytoplasmic region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   756   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0001128:Acids [Chemical]
   722 E C2917660:Amino Acid [Pharmacologic Substance]
   712   C1515860:Acidic Region [Amino Acid Sequence]
   704 E C0202406:Acid [Laboratory Procedure]

Phrase: "of the LRP -subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   804   C1711351:Subunit [Quantitative Concept]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "(Myc-LRP-ST)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "various LRP derivates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "were"

Phrase: "generated by PCR."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]
   790   C3146294:Generated [Activity]
Processing 00000000.tx.36: The fatty acylation (i.e. myristoylation and palmitoylation) signal sequence of Fyn tyrosine kinase (GCVQCKCKDKEATKLTEER) was fused to the N-terminal end of LRP-ST (FA-LRP-ST) (25). 

Phrase: "The fatty acylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596565:fatty acylation [Phenomenon or Process]
   861   C0001383:Acylation [Natural Phenomenon or Process]

Phrase: "(i.e. myristoylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0598434:myristoylation [Molecular Function]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "palmitoylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598435:Palmitoylation [Molecular Function]

Phrase: ")"

Phrase: "signal sequence of Fyn tyrosine kinase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0037081:Signal Sequence [Amino Acid Sequence]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]
   753   C1710082:Signal [Phenomenon or Process]

Phrase: "(GCVQCKCKDKEATKLTEER"

Phrase: ")"

Phrase: "was"

Phrase: "fused to the N-terminal end"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205088:Terminal [Temporal Concept]
   753   C0444930:End [Spatial Concept]
   753   C0699952:Fused [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C2746065:End [Temporal Concept]
   719 E C1414861:FUSE [Gene or Genome]
   719 E C1708111:Fuse [Manufactured Object]

Phrase: "of LRP-ST (FA-LRP-ST) (25"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   807   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   799   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   787   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0439849:Related [Qualitative Concept]
   787   C0445223:Related [Finding]
   787   C3272372:ST [Intellectual Product]
   716 E C0080103:Relation [Family Group]
   716 E C0869014:Relations [Social Behavior]

Phrase: ")."
Processing 00000000.tx.37: All of the constructs were subcloned into pLHCX vector (Clontech, Palo Alto, CA) for retrovirus production. 

Phrase: "All of the constructs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "subcloned into pLHCX vector"

Phrase: "(Clontech,"

Phrase: "Palo Alto,"

Phrase: "CA) for retrovirus production."
Processing 00000000.tx.38: Plasmids encoding the Gal4 DNA-binding domain (pMST), the Gal4 DNA-binding domain engineered into the cytoplasmic tail of APP695 (pMST-APP), the APP-Gal4 fusion protein with a deletion in the NPTY motif of the APP cytoplasmic tail (pMST-APP), and a Gal4 reporter plasmid encoding firefly luciferase (pG5E1B-luc) have been described (26) (kindly provided by Dr. T. Sudhof). 

Phrase: "Plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the Gal4 DNA-binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(pMST"

Phrase: ")"

Phrase: ","

Phrase: "the Gal4 DNA-binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "engineered into the cytoplasmic tail of APP695"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1511625:Cytoplasmic Tail [Cell Component]
   748   C0010834:Cytoplasmic [Cell Component]
   748   C0039259:Tail [Body Part, Organ, or Organ Component]
   748   C0521449:Cytoplasmic [Body Location or Region]
   748   C0878517:engineered [Professional or Occupational Group]

Phrase: "(pMST-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "the APP-Gal4 fusion protein with a deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   739   C0332466:Fusion [Functional Concept]
   739   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "in the NPTY motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "of the APP cytoplasmic tail"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1511625:Cytoplasmic Tail [Cell Component]
   804   C0010834:Cytoplasmic [Cell Component]
   804   C0039259:Tail [Body Part, Organ, or Organ Component]
   804   C0521449:Cytoplasmic [Body Location or Region]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(pMST-APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a Gal4 reporter plasmid encoding firefly luciferase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   799   C0162328:Firefly [Eukaryote]

Phrase: "(pG5E1B-luc"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "(kindly"

Phrase: "provided by Dr. T. Sudhof"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031831:DR [Professional or Occupational Group]
   760   C1707664:DR [Biomedical or Dental Material]
   760   C1999230:Provided [Activity]
   760   C2348314:Dr. [Conceptual Entity]
   760   C3540849:DR [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.39: The pLHCX-FE65 construct was engineered from pCMV-FE65 vector (a generous gift from Dr. T. Sudhof). 

Phrase: "The pLHCX-FE65 construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "engineered from pCMV-FE65 vector"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0442335:Vector [Spatial Concept]
   760   C0878517:engineered [Professional or Occupational Group]
   760   C1412459:FE65 [Gene or Genome]
   760   C1705099:Vector [Idea or Concept]

Phrase: "("

Phrase: "a generous gift from Dr. T. Sudhof"

Phrase: ")."
Processing 00000000.tx.40: Plasmid pRL-TK encoding Renilla luciferase was from Promega. 

Phrase: "Plasmid pRL-TK encoding Renilla luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was from Promega."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0072149:Promega [Lipid]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.41: All constructs were verified by sequencing. 

Phrase: "All constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "verified by sequencing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]
   790   C1711411:Verified [Functional Concept]
Processing 00000000.tx.42: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.43: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.44: cDNA constructs used in this study. 

Phrase: "cDNA constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.45: Diagram represents cDNA constructs used in this study. 

Phrase: "Diagram"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681494:Diagram [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "cDNA constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "used in this study."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.46: Myc-LRP-ST constructs contain the C-terminal 97 amino acid residues of LRP fused to a Myc tag (abbreviated as LRP-ST for soluble tail). 

Phrase: "Myc-LRP-ST constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C2827421:Construct [Classification]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the C-terminal 97 amino acid residues of LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "fused to a Myc tag ("
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0037293:Tag [Neoplastic Process]
   760   C0181496:Tag [Manufactured Object]
   760   C0699952:Fused [Functional Concept]
   760   C1710492:TAG [Gene or Genome]
   726 E C1414861:FUSE [Gene or Genome]
   726 E C1708111:Fuse [Manufactured Object]

Phrase: "abbreviated as LRP-ST"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C3272372:ST [Intellectual Product]

Phrase: "for soluble tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.47: The Myc-LRP-STNPTY and Myc-LRP-STNPVY are engineered from the Myc-LRP-ST construct, in which the first and second NPXY motif of LRP-ST was deleted, respectively. 

Phrase: "The Myc-LRP-STNPTY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Myc-LRP-STNPVY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "engineered from the Myc-LRP-ST construct,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   760   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   757   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C0878517:engineered [Professional or Occupational Group]
   739   C2827421:Construct [Classification]
   739   C3272372:ST [Intellectual Product]

Phrase: "in which"

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "second NPXY motif of LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0752190:Protein Motif [Spatial Concept]
   762   C1514562:Protein Motif [Amino Acid Sequence]
           Motif

Phrase: "was"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.48: (LRP-ST147) contains the first 47 amino acid residues of LRP-ST and has a FLAG tag at its C terminus. 

Phrase: "(LRP-ST147"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the first 47 amino acid residues of LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "has"

Phrase: "a FLAG tag at its C terminus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037293:Tag [Neoplastic Process]
   748   C0181496:Tag [Manufactured Object]
   748   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.49: (LRP-ST4897) contains the last 50 amino acid residues of LRP-ST and has a FLAG tag at its N terminus. 

Phrase: "(LRP-ST4897"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the last 50 amino acid residues of LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "has"

Phrase: "a FLAG tag at its N terminus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037293:Tag [Neoplastic Process]
   748   C0181496:Tag [Manufactured Object]
   748   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.50: The FA-LRP-ST is engineered from the LRP-ST by appending the fatty acylation signal peptide of Fyn tyrosine kinase at its N terminus using PCR.  

Phrase: "The FA-LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "is"

Phrase: "engineered from the LRP-ST"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0878517:engineered [Professional or Occupational Group]
   744   C3272372:ST [Intellectual Product]

Phrase: "by appending"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3242343:append [Temporal Concept]

Phrase: "the fatty acylation signal peptide of Fyn tyrosine kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0037081:Signal Peptide [Amino Acid Sequence]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "at its N terminus"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]
Processing 00000000.tx.51: Cell LinesChinese hamster ovary (CHO) cells and the LRP-deficient CHO cell line (13-5-1) stably expressing wild type APP751 (APP-WT) have been described previously (20). 

Phrase: "Cell LinesChinese hamster ovary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0029939:Ovary [Body Part, Organ, or Organ Component]
   812   C0227898:ovary [Body Part, Organ, or Organ Component]
   812   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "(CHO) cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the LRP-deficient CHO cell line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007600:Cell Line [Cell]
   793   C0205132:Line [Spatial Concept]
   793   C1550648:Line [Substance]
   793   C1552960:Line [Quantitative Concept]

Phrase: "(13-5-1"

Phrase: ")"

Phrase: "stably"

Phrase: "expressing"

Phrase: "wild type APP751"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(APP-WT)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C2700323:WT [Fish]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.52: To generate stable cell lines expressing various LRP constructs, VSV-G (glycoprotein of the vesicular stomatitis virus) pseudo-typed retroviruses were packaged and used to infect CHO cells (27). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "stable cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   983   C0598091:stable cell line [Cell]
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "expressing"

Phrase: "various LRP constructs,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C2827421:Construct [Classification]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "VSV-G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "(glycoprotein of the vesicular stomatitis virus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: ")"

Phrase: "pseudo-typed retroviruses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035366:Retroviruses [Virus]

Phrase: "were"

Phrase: "packaged"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0030176:packaged [Human-caused Phenomenon or Process]
   966 E C0013194:Package [Medical Device]
   966 E C2700580:Package [Manufactured Object]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "infect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]

Phrase: "CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.53: After infection, the cells were selected using hygromycin (250 g/ml), and antibiotic-resistant cells were expanded without further clonal selection. 

Phrase: "After infection,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0009450:Infection, NOS [Disease or Syndrome]
   928 E C0439663:Infected [Functional Concept]
   888 E C0030657:infectivity [Qualitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hygromycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063201:hygromycin [Organic Chemical]

Phrase: "(250 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "antibiotic-resistant cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "expanded without further clonal selection."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0036576:selection [Genetic Function]
   760   C0205229:expanded [Spatial Concept]
   760   C1517331:Further [Spatial Concept]
   760   C1522642:Clonal [Tissue]
   760   C1704387:Clonal [Qualitative Concept]
   726 E C0205108:far [Spatial Concept]
Processing 00000000.tx.54: AntibodiesThe polyclonal antibody 1704 recognizes the cytoplasmic domain of human LRP (20). 

Phrase: "AntibodiesThe polyclonal antibody 1704"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizes"

Phrase: "the cytoplasmic domain of human LRP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1511625:Cytoplasmic Domain [Cell Component]
   762   C0162808:Protein Domain [Spatial Concept]
   762   C1514562:Protein Domain [Amino Acid Sequence]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.55: The polyclonal antibody CT15, which reacts with the C-terminal 15 amino acid residues of APP, and the monoclonal antibodies 1G7/5A3 and 26D6, which recognize the ectodomain of APP, have been described previously (28, 29). 

Phrase: "The polyclonal antibody CT15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1412189:CT15 [Gene or Genome]
   734   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "reacts with the C-terminal 15 amino acid residues"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   807   C1707271:C-Terminal Amino Acid [Amino Acid Sequence]
           C-Terminal
   764   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C2917660:Amino Acid [Pharmacologic Substance]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "of APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "the monoclonal antibodies 1G7/5A3"

Phrase: "and"

Phrase: "26D6,"

Phrase: "which"

Phrase: "recognize"

Phrase: "the ectodomain of APP,"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.56: Monoclonal antibodies 9E10 against the Myc epitope sequence and Ab-1 against the -tubulin were obtained from Calbiochem. 

Phrase: "Monoclonal antibodies 9E10 against the Myc epitope sequence"

Phrase: "and"

Phrase: "Ab-1 against the -tubulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0041348:Tubulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2937342:tubulin [Cell Component]

Phrase: "were"

Phrase: "obtained from Calbiochem."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.57: Western Blot AnalysesCell lysates solubilized with 1% Nonidet P-40 or conditioned media were fractionated by SDS-PAGE in 412% NuPAGE Novex BisTris gels (Invitrogen) or 8% Tris-glycine gels to detect low molecular APP C-terminal fragments and A or sAPP, respectively. 

Phrase: "Western Blot AnalysesCell lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1881488:Lysate [Physical Object]

Phrase: "solubilized with 1% Nonidet P-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   753   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   753   C0439509:/40 [Temporal Concept]

Phrase: "or"

Phrase: "conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "fractionated by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   770   C1979893:Fractionated [Qualitative Concept]

Phrase: "in 412% NuPAGE Novex BisTris gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "or"

Phrase: "8% Tris-glycine gels to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "low molecular APP C-terminal fragments"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   820   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1168438:Protein C [Laboratory Procedure]
   812   C1418943:PROTEIN C [Gene or Genome]
   812   C1707271:C-Terminal [Amino Acid Sequence]
   812   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0205088:Terminal [Temporal Concept]
   793   C0332255:fragments [Functional Concept]
   793   C0486805:Fragments [Body Substance]
   793   C1705314:Terminal [Manufactured Object]
   793   C1705315:Terminal [Spatial Concept]
   760 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "sAPP,"

Phrase: "respectively."
Processing 00000000.tx.58: In all cases, gel loading was normalized to total protein content in the cell extract or the corresponding cell extracts when medium samples were used. 

Phrase: "In all cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "gel loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "normalized to total protein content"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0555903:Total protein [Laboratory Procedure]
   806   C1261360:total protein [Laboratory or Test Result]
   797 E C0439177:Protein.total [Quantitative Concept]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0423896:Content [Mental Process]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0456205:Content [Conceptual Entity]
   760   C1882115:Normalized [Research Activity]

Phrase: "in the cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828366:Extract [Substance]

Phrase: "or"

Phrase: "the corresponding cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0007592:Cell Extracts [Cell Component]
   793   C2828366:Extract [Substance]

Phrase: "when"

Phrase: "medium samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.59: Western blotting was carried out with the indicated antibodies and detected by enhanced chemiluminescence (Pierce). 

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with the indicated antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "detected by enhanced chemiluminescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0442726:Detected [Finding]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2349975:Enhanced [Activity]

Phrase: "(Pierce"

Phrase: ")."
Processing 00000000.tx.60: Quantitation of the chemiluminescence signal was done using a charge-coupled device imaging system (GeneGnome, Syngene, Frederick, MD). 

Phrase: "Quantitation of the chemiluminescence signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "was"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a charge-coupled device imaging system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   853   C1704459:Device System [Medical Device]
           System
   840   C2697665:Imaging System [Manufactured Object]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   733 E C0205373:Systemic [Functional Concept]
   717   C1455741:Charge coupled device [Medical Device]

Phrase: "(GeneGnome,"

Phrase: "Syngene,"

Phrase: "Frederick,"

Phrase: "MD)."
Processing 00000000.tx.61: All experiments were performed at least three times, and each experiment was done in duplicate or in triplicate. 

Phrase: "All experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed at least three times,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0884358:Performed [Functional Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C2947996:Perform [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "done in duplicate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205173:Duplicate [Functional Concept]
   790   C1272695:Done [Qualitative Concept]
   790   C2746065:Done [Temporal Concept]
   790   C3539942:Duplicate [Intellectual Product]

Phrase: "or in triplicate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205174:Triplicate [Quantitative Concept]
Processing 00000000.tx.62: Data are presented as the mean  S.E. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the mean"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0444504:Mean [Quantitative Concept]
   770   C0449450:Presented [Idea or Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.63: Differences were analyzed by Student's t test or one-way analysis of variance, followed by post hoc comparisons of group means using the Tukey test. 

Phrase: "Differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed by Student's t test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0022885:Test [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]

Phrase: "or"

Phrase: "one-way analysis of variance,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1709320:One-way Analysis of Variance [Quantitative Concept]
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "followed by post hoc comparisons of group means"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0441833:Group [Idea or Concept]
   744   C0687676:Post [Temporal Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1704687:Post [Manufactured Object]
   744   C1704970:Means [Conceptual Entity]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   711 E C0444504:Mean [Quantitative Concept]
   711   C1707455:Comparison [Activity]
   711 E C1719822:Follow [Intellectual Product]
   711 E C2347634:Mean [Quantitative Concept]
   711 E C2348143:Mean [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Tukey test."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]
Processing 00000000.tx.64: Statistical differences with two-tailed probability values of p < 0.05 were taken as significant. 

Phrase: "Statistical differences with two-tailed probability values of p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C1705241:*Difference [Quantitative Concept]
   704   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "taken as significant."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1546944:Significant [Qualitative Concept]
   790   C1883727:Taken [Conceptual Entity]
   756 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.65: Extraction of Membrane FractionCells in a 10-cm dish were washed twice with ice-cold phosphate-buffered saline and scraped in 1 ml of phosphate-buffered saline. 

Phrase: "Extraction of Membrane FractionCells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0684295:extraction [Laboratory Procedure]

Phrase: "in a 10-cm dish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold phosphate-buffered saline"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1720725:Twice [Intellectual Product]
   748   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "scraped in 1 ml of phosphate-buffered saline."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   744   C0031701:phosphate [Organophosphorus Compound]
   744   C0036082:Saline [Substance]
   744   C0184933:scraped [Therapeutic or Preventive Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0444082:scraped [Body Substance]
   744   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.66: The scraped cells were collected by low speed centrifugation (500 x g for 1 min). 

Phrase: "The scraped cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected by low speed centrifugation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0205251:low [Qualitative Concept]
   760   C0678536:Speed [Quantitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   760   C1550472:low [Idea or Concept]

Phrase: "(500 x g for 1 min)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0560021:g/min [Quantitative Concept]
   783   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   753   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.67: Cells were then resuspended in 1 ml of hypotonic buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA) containing 1x complete protease inhibitor mixture (Roche Applied Science) and homogenized by passing five times through a 25-gauge needle and five times through a 27-gauge needle. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "resuspended in 1 ml of hypotonic buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0241938:Hypotonic [Pathologic Function]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "(10 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "containing 1x complete protease inhibitor mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0439962:Mixture [Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "homogenized"

Phrase: "by passing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006539:BY [Geographic Area]
   827   C2828386:Pass [Finding]

Phrase: "five times through a 25-gauge needle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "five times through a 27-gauge needle."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.68: To prepare a post-nuclear supernatant, the homogenate was centrifuged at 1000 x g for 15 min at 4 C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prepare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521827:Prepare [Functional Concept]

Phrase: "a post-nuclear supernatant,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0521447:Nuclear [Spatial Concept]
   827   C0687676:Post [Temporal Concept]
   827   C1550101:Supernatant [Body Substance]
   827   C1704687:Post [Manufactured Object]
   755 E C1514253:Postal [Functional Concept]

Phrase: "the homogenate"

Phrase: "was"

Phrase: "centrifuged at 1000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.69: The membrane fraction was isolated from the post-nuclear supernatant by centrifugation at 20,000 x g for 45 min at 4 C. 

Phrase: "The membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "isolated from the post-nuclear supernatant"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0205409:Isolated [Functional Concept]
   753   C0521447:Nuclear [Spatial Concept]
   753   C0687676:Post [Temporal Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1550101:Supernatant [Body Substance]
   753   C1704687:Post [Manufactured Object]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 20,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 45 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.70: The supernatant (cytosolic fraction) was saved for further analysis at 80 C. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(cytosolic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "saved for further analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1517331:Further [Spatial Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C0205108:far [Spatial Concept]
   737   C2347840:Save [Machine Activity]

Phrase: "at 80 C."
Processing 00000000.tx.71: The pellet (membrane fraction) was resuspended in 100 lof radioimmune precipitation assay buffer (50 mM Tris, 150 mM NaCl, 0.02% NaN3, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS) and cleared by a spin at 20,000 x g for 10 min at 4 C. 

Phrase: "The pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "(membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "resuspended in 100 lof radioimmune precipitation assay buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0005507:Assay [Laboratory Procedure]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0032931:Precipitation [Natural Phenomenon or Process]
   744   C0032932:Precipitation [Molecular Function]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]
   744   C1642401:% precipitation [Quantitative Concept]
   744   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "(50 mM Tris,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.02% NaN3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.5% deoxycholate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "0.1% SDS)"

Phrase: "and"

Phrase: "cleared by a spin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0521097:Cleared by [Functional Concept]
           cleared
   770   C1415347:SPIN [Gene or Genome]
   770   C1823107:SPIN [Gene or Genome]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "at 20,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.72: Metabolic LabelingConfluent cells were incubated in 150 Ci/ml [35S]methionine/cysteine for 10 min or 3 h to determine the turnover of full-length APP or APP C-terminal fragments (CTFs), respectively. 

Phrase: "Metabolic LabelingConfluent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in 150 Ci/ml [35S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2348025:Ci/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "]methionine/cysteine for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C2927891:Cysteine / Methionine [Pharmacologic Substance]
   760   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "3 h to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0041119:3 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "determine"

Phrase: "the turnover of full-length APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597297:Protein Turnover [Molecular Function]
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]

Phrase: "or"

Phrase: "APP C-terminal fragments (CTFs),"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   841   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.73: Following metabolic labeling, the cells were either lysed immediately (time 0) or chased for 1, 2, or 4 h. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "metabolic labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "either"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "(time 0"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "chased for 1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.74: The full-length APP and APP CTFs were immunoprecipitated with polyclonal antibody CT15. 

Phrase: "The full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APP CTFs"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   841   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with polyclonal antibody CT15."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1412189:CT15 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.75: The immunoprecipitates were fractionated by SDS-PAGE (8% Tris-glycine gels for full-length APP and 412% NuPAGE Novex BisTris gels for APP-CTF) and exposed to a phosphorimaging screen for quantitation. 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "fractionated by SDS-PAGE (8% Tris-glycine gels"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   744   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   744   C0522461:Glycine [Plant]
   744   C0814229:TRI [Intellectual Product]
   744   C1704732:Page [Intellectual Product]
   744   C1979893:Fractionated [Qualitative Concept]
   711 E C1382104:Gel [Substance]

Phrase: "for full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "412% NuPAGE Novex BisTris gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0017243:Gels [Biomedical or Dental Material]
   771 E C1382104:Gel [Substance]

Phrase: "for APP-CTF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   858   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "exposed to a phosphorimaging screen"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0220908:screen [Health Care Activity]
   760   C1305399:screen [Functional Concept]
   760   C1705053:Screen [Medical Device]

Phrase: "for quantitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantitation [Quantitative Concept]
Processing 00000000.tx.76: Internalization AssayTo measure internalization of cell-surface APP, iodinated 1G7 antibody was added to confluent cultures of APP-WT CHO and MycST cells at 37 C for 30 min exactly as described previously (20). 

Phrase: "Internalization AssayTo measure internalization of cell-surface APP,"

Phrase: "iodinated 1G7 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to confluent cultures of APP-WT CHO"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0010453:Cultures [Idea or Concept]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205200:Confluent [Qualitative Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1524062:Added [Functional Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C2700323:WT [Fish]
   706 E C0220814:culture [Functional Concept]
   706 E C0430400:Culture [Laboratory Procedure]
   706 E C1883712:Add [Functional Concept]
   706 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "MycST cells at 37 C"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "for 30 min exactly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0456693:/30 min [Temporal Concept]
   901   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.77: In brief, after incubation, the cells were rapidly chilled on ice, and the reaction was quenched by the addition of ice-cold binding medium. 

Phrase: "In brief,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282927:brief [Qualitative Concept]
  1000   C1879313:Brief [Temporal Concept]

Phrase: "after"

Phrase: "incubation,"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "chilled on ice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0085593:Chill [Sign or Symptom]

Phrase: "and"

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "quenched by the addition of ice-cold binding medium."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   764   C0456963:Ice cold [Qualitative Concept]
   762   C0456913:Cold medium [Finding]
   762   C1323394:ice binding [Molecular Function]
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0009458:Medium [Intellectual Product]
   742   C0020746:Ice [Inorganic Chemical]
   742   C0234192:Cold [Physiologic Function]
   742   C0243122:binding [Functional Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1705217:Medium [Substance]
   742   C1883712:Addition [Functional Concept]
   742   C3244283:medium [Intellectual Product]
Processing 00000000.tx.78: The chilled cells were washed extensively, and the remaining surface antibody was detached by two acid washes. 

Phrase: "The chilled cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively,"

Phrase: "and"

Phrase: "the remaining surface antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "detached by two acid washes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0205448:Two [Quantitative Concept]
   760   C0687118:Detached [Functional Concept]
   760   C1561504:detached [Idea or Concept]
   726   C0441648:Wash [Activity]
Processing 00000000.tx.79: The cells were then lysed and collected for analysis. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "and"

Phrase: "collected for analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1524024:analysis [Functional Concept]
Processing 00000000.tx.80: Acid-labile and acid-resistant radioactivity represents the surface and internalized pools of APP, respectively. 

Phrase: "Acid-labile"

Phrase: "and"

Phrase: "acid-resistant radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "internalized pools of APP,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0337051:pools [Geographic Area]
   719 E C1509144:pool [Clinical Attribute]
   719 E C2349200:Pool [Functional Concept]

Phrase: "respectively."
Processing 00000000.tx.81: Specific binding was determined after subtraction of the radioactivity counts obtained from parallel cultures of untransfected CHO cells. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "determined after subtraction of the radioactivity counts"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0034553:Radioactivity [Natural Phenomenon or Process]
   748   C0439157:counts [Quantitative Concept]
   748   C2348589:Subtraction [Phenomenon or Process]
   714 E C0750480:Count [Activity]
   714 E C1705566:Count [Quantitative Concept]

Phrase: "obtained from parallel cultures of untransfected CHO cells."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   770   C0085080:CHO Cells [Cell]
   767   C0007585:cells cultures [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C0010453:Cultures [Idea or Concept]
   744   C1301820:Obtained [Functional Concept]
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]
   744   C3282337:Cells [Cell]
   711 E C0220814:culture [Functional Concept]
   711 E C0430400:Culture [Laboratory Procedure]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1706701:Obtain [Activity]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.82: The ratio of acid-resistant to acid-labile counts therefore provided a measure of the internalized versus cell-surface pools of APP. 

Phrase: "The ratio of acid-resistant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to acid-labile counts therefore"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0439157:counts [Quantitative Concept]
   779 E C0750480:Count [Activity]
   779 E C1705566:Count [Quantitative Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "a measure of the internalized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079809:Measure [Quantitative Concept]
   760   C0242485:Measure [Functional Concept]

Phrase: "versus"

Phrase: "cell-surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "pools of APP."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0337051:Pool [Geographic Area]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1509144:pool [Clinical Attribute]
   760   C1709634:Precursor [Idea or Concept]
   760   C2349200:Pool [Functional Concept]
Processing 00000000.tx.83: Data are from three separate experiments, and each experiment was performed in triplicate. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are from three separate experiments,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205449:Three [Quantitative Concept]
   760   C0443299:Separate [Spatial Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1551058:Are [Quantitative Concept]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed in triplicate."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205174:Triplicate [Quantitative Concept]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.84: Luciferase Reporter AssaySubconfluent CHO cells were transiently transfected with the following combinations of plasmids (0.25 g of each): 1) pMST + pG5EIB-luc + pLHCX; 

Phrase: "Luciferase Reporter AssaySubconfluent CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0085080:CHO Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with the following combinations of plasmids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   748   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0453882:Combinations [Manufactured Object]
   714 E C0205195:Combination [Qualitative Concept]
   714   C0332283:follow [Temporal Concept]
   714   C1719822:Follow [Intellectual Product]
   714 E C1947911:Combination [Physical Object]

Phrase: "(0.25 g of each"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "pMST + pG5EIB-luc + pLHCX"

Phrase: ";"
Processing 00000000.tx.85: 2) pMST-APP + pG5EIB-luc + pLHCX; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "pMST-APP + pG5EIB-luc + pLHCX"

Phrase: ";"
Processing 00000000.tx.86: 3) pMST-APP + pG5EIB-luc + pLHCX-FE65 + pLHCX; 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "pMST-APP + pG5EIB-luc + pLHCX-FE65 + pLHCX"

Phrase: ";"
Processing 00000000.tx.87: 4) pMST-APP+ pG5EIB-luc + pLHCX-FE65 + pLHCX; 

Phrase: "4"

Phrase: ")"

Phrase: "pMST-APP+ pG5EIB-luc + pLHCX-FE65 + pLHCX"

Phrase: ";"
Processing 00000000.tx.88: and 5) pMST-APP + pG5EIB-luc + pLHCX-FE65 + pLHCX-MycST. 

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "pMST-APP + pG5EIB-luc + pLHCX-FE65 + pLHCX-MycST."
Processing 00000000.tx.89: 20 ng of pRL-TK was added to each plasmid mix to control for transfection efficiency. 

Phrase: "20 ng of pRL-TK"

Phrase: "was"

Phrase: "added to each plasmid"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205430:Mix [Functional Concept]
  1000   C1421951:MIX [Gene or Genome]
  1000   C1720722:Mix [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for transfection efficiency."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0013682:Efficiency [Quantitative Concept]
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.90: 48 h after transfection, the cells were washed twice with phosphate-buffered saline and lysed using the 1x lysis buffer from the dual luciferase reporter assay system (Promega). 

Phrase: "48 h after transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with phosphate-buffered saline"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 1x lysis buffer from the dual luciferase reporter assay system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: ")."
Processing 00000000.tx.91: The firefly and Renilla luciferase activities were quantified using a dual injector luminometer (EC & G Berthold). 

Phrase: "The firefly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162328:Firefly [Eukaryote]

Phrase: "and"

Phrase: "Renilla luciferase activities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   884   C1151115:luciferase activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a dual injector luminometer"

Phrase: "(EC & G Berthold"

Phrase: ")."
Processing 00000000.tx.92: The firefly luciferase values were normalized against the Renilla luciferase value after background values from the wells with no cell lysates were subtracted. 

Phrase: "The firefly luciferase values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
   734   C0311727:Firefly luciferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "normalized against the Renilla luciferase value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C1093003:Renilla [Eukaryote]
   753   C1522609:Value [Quantitative Concept]
   753   C1882115:Normalized [Research Activity]

Phrase: "after background values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "from the wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205170:Well [Qualitative Concept]
   966   C3146287:Well [Manufactured Object]

Phrase: "with no cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "subtracted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1719767:Subtract [Intellectual Product]
   966   C2348589:Subtract [Phenomenon or Process]
Processing 00000000.tx.93: The values were expressed as fold induction over Gal4 (i.e. value from plasmid combination 1).  

Phrase: "The values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "expressed as fold induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205263:Induction [Functional Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "over Gal4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1416832:GAL4 [Gene or Genome]

Phrase: "(i.e. value from plasmid combination 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1522609:Value [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.94: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Effect of LRP-soluble Tail (LRP-ST) Expression on APP ProcessingTo examine the effects of LRP-ST expression on APP processing, Myc-tagged LRP-ST (Myc-LRP-ST) was stably expressed in APP-WT CHO cells (herein referred to as MycST cells). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Effect of LRP-soluble Tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(LRP-ST) Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0597360:receptor expression [Genetic Function]
   839   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "on APP ProcessingTo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "examine"

Phrase: "the effects of LRP-ST expression"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Myc-tagged LRP-ST (Myc-LRP-ST)"

Phrase: "was"

Phrase: "stably"

Phrase: "expressed in APP-WT CHO cells"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085080:CHO Cells [Cell]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C2700323:WT [Fish]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(herein"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.95: Expression of Myc-LRP-ST was examined by immunoblotting with a LRP C-terminal antibody. 

Phrase: "Expression of Myc-LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "examined by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0332128:Examined [Finding]

Phrase: "with a LRP C-terminal antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   845   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.96: When whole cell lysates were separated into cytosolic and membrane fractions, full-length LRP (600 kDa) and LRP -chain (85 kDa) were detected in membrane fractions from both parental control and Myc-LRP-ST-transfected cells (Fig. 2A, upper panel). 

Phrase: "When"

Phrase: "whole cell lysates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   827   C0007634:Cell [Cell]
   827   C0444667:Whole [Quantitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "separated into cytosolic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086972:Separated [Finding]
   790   C0443299:separated [Spatial Concept]
   790   C0687118:Separated [Functional Concept]
   790   C1383501:Cytosolic [Cell Component]

Phrase: "and"

Phrase: "membrane fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "full-length LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(600 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "LRP -chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0337112:Chain [Manufactured Object]
   804   C1524075:Chain [Idea or Concept]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "(85 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "were"

Phrase: "detected in membrane fractions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0025255:Membrane [Tissue]
   770   C0442726:Detected [Finding]
   770   C0596901:Membrane [Cell Component]
   770   C1264633:Fractions [Quantitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1706182:Membrane [Manufactured Object]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "from both parental control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0814584:parental control [Social Behavior]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "Myc-LRP-ST-transfected cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2A,"

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.97: As anticipated, the Myc-LRP-ST lacking the transmembrane domain was detected in the cytosolic fraction of MycST cells only. 

Phrase: "As"

Phrase: "anticipated"

Phrase: ","

Phrase: "the Myc-LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the transmembrane domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1519623:Transmembrane Domain [Amino Acid Sequence]
   861   C1167322:transmembrane [Cell Component]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C2752508:transmembrane [Cell Component]
   861   C3541951:Domain [Intellectual Product]

Phrase: "was"

Phrase: "detected in the cytosolic fraction of MycST cells only."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   745   C0805525:Cell Fraction [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0205171:Only [Quantitative Concept]
   742   C0442726:Detected [Finding]
   742   C1383501:Cytosolic [Cell Component]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1554103:Fraction [Idea or Concept]
   742   C1720467:Only [Intellectual Product]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.98: The recently described 25-kDa C-terminal fragment of LRP representing the substrate for -secretase intramembrane proteolysis (9) was also detected in membrane fractions of both cell lines (Fig. 2A, lower panel, asterisk). 

Phrase: "The recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "25-kDa C-terminal fragment of LRP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   775   C1418944:PROTEIN C RECEPTOR [Gene or Genome]
   760   C1707271:C-Terminal [Amino Acid Sequence]
   757   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1168438:Protein C [Laboratory Procedure]
   757   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   757   C1418943:PROTEIN C [Gene or Genome]
   757   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205088:Terminal [Temporal Concept]
   739   C0332255:fragment [Functional Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C1708096:Fragment [Qualitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the substrate for -secretase intramembrane proteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: "(9"

Phrase: ")"

Phrase: "was"

Phrase: "also"

Phrase: "detected in membrane fractions of both cell lines"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   770   C0007600:Cell lines [Cell]
   767   C0007603:Cell Membrane [Cell Component]
   767   C0805525:Cell fractions [Cell Component]
   767   C3161472:Cell Membrane [Cell Component]
   754   C1264633:Fraction of [Quantitative Concept]
           Fractions
   744   C0007634:Cell [Cell]
   744   C0025255:Membrane [Tissue]
   744   C0205132:lines [Spatial Concept]
   744   C0442726:Detected [Finding]
   744   C0596901:Membrane [Cell Component]
   744   C1269647:Cell [Cell]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1704653:Cell [Medical Device]
   744   C1706182:Membrane [Manufactured Object]
   744   C1948049:Cell [Spatial Concept]
   711 E C1550648:Line [Substance]
   711 E C1552960:Line [Quantitative Concept]
   711 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2A,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.99: Expression of the Myc-LRP-ST fragment was also detected by immunoblotting with an antibody that recognized the Myc epitope tag (Fig. 2B). 

Phrase: "Expression of the Myc-LRP-ST fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "also"

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "with an antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "recognized"

Phrase: "the Myc epitope tag (Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0450354:2b [Intellectual Product]
   804   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.100: Expression of Myc-LRP-ST did not alter the expression of APP (Fig. 3, top panel). 

Phrase: "Expression of Myc-LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the expression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.101: However, there was a significant 2-fold increase in the level of APP CTF in MycST cells as compared with control APP-WT CHO cells (Fig. 3, middle panel). 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "a significant 2-fold increase in the level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "of APP CTF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   858   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with control APP-WT CHO cells"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0085080:CHO Cells [Cell]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243148:control [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550141:Control [Substance]
   742   C1707455:Compared [Activity]
   742   C1709634:Precursor [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700323:WT [Fish]
   742   C3274648:Control [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.102: Previously, we reported that in LRP-deficient cells, the levels of APP CTFs were substantially reduced (20). 

Phrase: "Previously,"

Phrase: "we"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that in LRP-deficient cells,"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   750   C1514760:Receptor Cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0011155:Deficient [Functional Concept]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1636779:% deficient [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "the levels of APP CTFs"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0919677:Protein C level [Laboratory Procedure]
   745   C0428479:Protein level [Laboratory or Test Result]
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "substantially"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.103: View larger version (29K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.104: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.105: Stable expression of Myc-LRP-ST (MycST) in CHO cells overexpressing APP751 (APP-WT CHO). 

Phrase: "Stable expression of Myc-LRP-ST (MycST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "APP751"

Phrase: "(APP-WT CHO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.106: Full-length (FL-LRP) and the -chain of LRP are recovered in the membrane fraction (A, upper panel) and detected using LRP polyclonal antibody 1704. 

Phrase: "Full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(FL-LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "the -chain of LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0337112:Chain [Manufactured Object]
   748   C1524075:Chain [Idea or Concept]

Phrase: "are"

Phrase: "recovered in the membrane fraction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0521108:recovered [Qualitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1706182:Membrane [Manufactured Object]
   726 E C2004454:recover [Organism Function]

Phrase: "(A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LRP polyclonal antibody 1704."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   877   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   861   C0034805:receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   829   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   829   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   818   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0439849:Related [Qualitative Concept]
   795   C0445223:Related [Finding]
   724 E C0080103:Relation [Family Group]
   724 E C0869014:Relations [Social Behavior]
Processing 00000000.tx.107: The Myc-LRP-ST fragment in the cytosolic fraction is detected using LRP (A) or Myc (B) antibodies. 

Phrase: "The Myc-LRP-ST fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   829   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   795   C0332255:fragment [Functional Concept]
   795   C1708096:Fragment [Qualitative Concept]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "in the cytosolic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")"

Phrase: "or"

Phrase: "Myc (B) antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.108: Asterisk indicates the 25-kDa C-terminal fragment of LRP representing the substrate for -secretase intramembrane proteolysis (9).  

Phrase: "Asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "the 25-kDa C-terminal fragment of LRP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C1418944:PROTEIN C RECEPTOR [Gene or Genome]
   756   C1707271:C-Terminal [Amino Acid Sequence]
   754   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   754   C1168438:Protein C [Laboratory Procedure]
   754   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   754   C1418943:PROTEIN C [Gene or Genome]
   754   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205088:Terminal [Temporal Concept]
   738   C0332255:fragment [Functional Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C1708096:Fragment [Qualitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the substrate for -secretase intramembrane proteolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1710236:Substrate [Manufactured Object]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.109: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.110: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.111: Increased level of C-terminal fragment (CTF) of APP in MycST cells. 

Phrase: "Increased level of C-terminal fragment (CTF) of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C0919677:Protein C level [Laboratory Procedure]
   757   C0428479:Protein level [Laboratory or Test Result]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C1547707:Level [Geographic Area]
   739   C2946261:Level [Pharmacologic Substance]

Phrase: "in MycST cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.112: Expression of the full-length APP level in a duplicate sample of cell extracts is unchanged following stable expression of Myc-LRP-ST (top panel). 

Phrase: "Expression of the full-length APP level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1171362:expression protein [Genetic Function]
   762   C3244092:expression level [Idea or Concept]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in a duplicate sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "of cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "is"

Phrase: "unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442739:Unchanged [Finding]
  1000   C2346711:Unchanged [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "stable expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of Myc-LRP-ST (top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0441833:Panel [Idea or Concept]
   793   C1999270:Panel [Intellectual Product]
   793   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.113: However, there is an 2-fold increase in APP CTF levels in MycST cells as compared with APP-WT CHO cells (middle panel). 

Phrase: "However,"

Phrase: "there"

Phrase: "is"

Phrase: "an 2-fold increase in APP CTF levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0442805:Increase [Functional Concept]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with APP-WT CHO cells"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085080:CHO Cells [Cell]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1707455:Compared [Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C2700323:WT [Fish]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.114: -tubulin levels were determined with a monoclonal antibody (Ab-1) in the same cell lysate to ensure equal loading (bottom panel).  

Phrase: "-tubulin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined with a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]

Phrase: "(Ab-1"

Phrase: ")"

Phrase: "in the same cell lysate to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "equal loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "(bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.115: We next assayed for sAPP secretion, because CTF generation and sAPP secretion are frequently correlated with each other. 

Phrase: "We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "assayed for sAPP secretion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "because"

Phrase: "CTF generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0079411:Generation [Temporal Concept]
   812   C3146294:Generation [Activity]
   719 E C1414672:Genesis [Gene or Genome]
   719 E C2984892:Genesis [Gene or Genome]

Phrase: "and"

Phrase: "sAPP secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "are"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "correlated with each other."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707520:Correlated [Qualitative Concept]
Processing 00000000.tx.116: As predicted, there was an 2-fold increase in total sAPP secretion in conditioned medium from MycST cells as compared with controls (Fig. 4A). 

Phrase: "As"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "an 2-fold increase in total sAPP secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "in conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "from MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.117: To determine whether the -or -secretase-derived sAPP was preferentially affected by LRP-ST, the same conditioned medium was subjected to additional immunoblotting using monoclonal antibody 26D6, which reacts with the first 12 residues of the A sequence contained in sAPP but not in sAPP (14, 28). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the -or -secretase-derived sAPP"

Phrase: "was"

Phrase: "preferentially"

Phrase: "affected by LRP-ST,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392760:Affected [Functional Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1314939:Affected [Functional Concept]
   748   C3272372:ST [Intellectual Product]
   714 E C0001721:Affect [Mental Process]

Phrase: "the same conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "subjected to additional immunoblotting"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0020985:Immunoblotting [Laboratory Procedure]
   770   C1524062:Additional [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal antibody 26D6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "reacts with the first 12 residues of the A sequence"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0205435:First [Quantitative Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1279901:First [Qualitative Concept]
   739   C1519249:Sequence [Functional Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "contained in sAPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332256:contained [Functional Concept]
   790   C2700400:Contained [Activity]

Phrase: "but"

Phrase: "not in sAPP (14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1518422:Not [Functional Concept]

Phrase: "28"

Phrase: ")."
Processing 00000000.tx.118: Surprisingly, there was only a small non-significant (15%) increase in sAPP in MycST cells (Fig. 4B), suggesting that the observed 2-fold increase in total sAPP secretion mainly resulted from sAPP. 

Phrase: "Surprisingly,"

Phrase: "there"

Phrase: "was"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small non-significant"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0237881:significant [Quantitative Concept]
   827   C0750502:Significant [Idea or Concept]
   827   C1518422:Non [Functional Concept]
   827   C1546944:Significant [Qualitative Concept]

Phrase: "(15%"

Phrase: ")"

Phrase: "increase in sAPP"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   790   C0442805:Increase [Functional Concept]
   734 E C1517378:Gain [Quantitative Concept]
   706 E C0205217:Increased [Quantitative Concept]
   706 E C0439661:Acquired [Temporal Concept]
   706 E C0442808:Increasing [Functional Concept]
   706 E C1301820:Obtain [Functional Concept]
   706 E C1706701:Acquire [Activity]
   706 E C3245488:acquired [Intellectual Product]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the observed 2-fold increase in total sAPP secretion mainly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "resulted from sAPP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]
Processing 00000000.tx.119: Consistent with this interpretation, -secretase-derived APP CTF was also increased by >50% in Myc-LRP-ST-expressing cells (Fig. 4C) concomitant with an 2-fold increase in A secretion (Fig. 4D). 

Phrase: "Consistent with this interpretation, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "secretase-derived APP CTF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   836   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   812   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1168438:Protein C [Laboratory Procedure]
   812   C1418943:PROTEIN C [Gene or Genome]
   812   C1707271:C-Terminal [Amino Acid Sequence]
   812   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0205088:Terminal [Temporal Concept]
   793   C0332255:fragment [Functional Concept]
   793   C1705314:Terminal [Manufactured Object]
   793   C1705315:Terminal [Spatial Concept]
   793   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "also"

Phrase: "increased by"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
   833   C0205217:Increased [Quantitative Concept]
   833   C0442805:Increased [Functional Concept]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C1301820:Obtain [Functional Concept]
   740 E C1706701:Acquire [Activity]
   740 E C3245488:acquired [Intellectual Product]

Phrase: ">50%"

Phrase: "in Myc-LRP-ST-expressing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "concomitant with an 2-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0521115:Concomitant [Temporal Concept]

Phrase: "in A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.120: The increase in A level was not because of the Myc tag attached to LRP-ST, because the expression of LRP-ST alone showed similar results (Fig. 4E). 

Phrase: "The increase in A level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not because of the Myc tag"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0037293:Tag [Neoplastic Process]
   753   C0181496:Tag [Manufactured Object]
   753   C1518422:Not [Functional Concept]
   753   C1710492:TAG [Gene or Genome]

Phrase: "attached to LRP-ST,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   781   C1179410:Attached_to relation [Intellectual Product]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0231441:Attached [Finding]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C3272372:ST [Intellectual Product]
   714 E C1314972:ATTACH [Intellectual Product]

Phrase: "because"

Phrase: "the expression of LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0597360:receptor expression [Genetic Function]
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "(Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.121: These results taken together indicate that LRP-ST expression in CHO cells augments APP processing through a -secretase-mediated pathway. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "indicate"

Phrase: "that LRP-ST expression in CHO cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "augments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "APP processing through a -secretase-mediated pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]
Processing 00000000.tx.122: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.123: 4. 

Phrase: "4."
Processing 00000000.tx.124: Increased level of secreted -cleaved APP (sAPP), -secretase-cleaved CTF (CTF) and A in MycST cells. 

Phrase: "Increased level of secreted -cleaved APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "(sAPP"

Phrase: ")"

Phrase: ", -"

Phrase: "secretase-cleaved CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1707271:C-Terminal [Amino Acid Sequence]
   804   C0205088:Terminal [Temporal Concept]
   804   C0332255:fragment [Functional Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "(CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A in MycST cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.125: A, a 2-fold increase in total sAPP level is detected in the conditioned medium from MycST cells as compared with control cells seen here by immunoblotting sAPP from conditioned medium using APP monoclonal antibodies (5A3 and 1G7). 

Phrase: "A,"

Phrase: "a 2-fold increase in total sAPP level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "detected in the conditioned medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0439536:Medium [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]

Phrase: "from MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with control cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0007634:Cells [Cell]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "here by immunoblotting sAPP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "from conditioned medium"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "APP monoclonal antibodies"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   840   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1317659:Protein.monoclonal [Laboratory or Test Result]
   836   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0746619:monoclonal [Finding]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(5A3"

Phrase: "and"

Phrase: "1G7"

Phrase: ")."
Processing 00000000.tx.126: B, only a small increase in -secretase-cleaved sAPP (sAPP) level was seen following immunoblotting-conditioned medium with APP monoclonal antibody 26D6 that recognizes the C terminus of sAPP (or first 12 residues of A). 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small increase in -secretase-cleaved sAPP (sAPP) level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0441889:Level [Qualitative Concept]
   793   C0456079:Level [Classification]
   793   C1547707:Level [Geographic Area]
   793   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunoblotting-conditioned medium with APP monoclonal antibody 26D6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   739   C0009458:Medium [Intellectual Product]
   739   C0439536:Medium [Quantitative Concept]
   739   C1705217:Medium [Substance]
   739   C3244283:medium [Intellectual Product]

Phrase: "that"

Phrase: "recognizes"

Phrase: "the C terminus of sAPP ("

Phrase: "or"

Phrase: "first 12 residues of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.127: C, approximately 50% more CTF as compared with APP-WT CHO cells was seen in MycST cells using the APP antibody 26D6, which recognizes only CTF but not CTF. 

Phrase: "C,"

Phrase: "approximately 50% more CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1707271:C-Terminal [Amino Acid Sequence]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "as"

Phrase: "compared with APP-WT CHO cells"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085080:CHO Cells [Cell]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1707455:Compared [Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C2700323:WT [Fish]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "seen in MycST cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205397:Seen [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0042789:see [Organism Function]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947903:See [Activity]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the APP antibody 26D6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "which"

Phrase: "recognizes"

Phrase: "only CTF"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "but"

Phrase: "not CTF."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1707271:C-Terminal [Amino Acid Sequence]
   812   C0205088:Terminal [Temporal Concept]
   812   C0332255:fragment [Functional Concept]
   812   C1705314:Terminal [Manufactured Object]
   812   C1705315:Terminal [Spatial Concept]
   812   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.128: D, 2-fold more A was secreted into the medium of MycST cells as compared with APP-WT CHO cells. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "2-fold more A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "secreted into the medium of MycST cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0007634:Cells [Cell]
   748   C0009458:Medium [Intellectual Product]
   748   C0439536:Medium [Quantitative Concept]
   748   C1327616:Secreted [Cell Function]
   748   C1705217:Medium [Substance]
   748   C3244283:medium [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with APP-WT CHO cells."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085080:CHO Cells [Cell]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1707455:Compared [Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C2700323:WT [Fish]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: Representative immunoblots are shown in the inset. 

Phrase: "Representative immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "are"

Phrase: "shown in the inset."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.130: Note that peptide A 140 peptide standard was loaded in the first lane from the left. 

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that peptide A 140 peptide standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1442989:Standard [Qualitative Concept]
   804   C2828392:Standard [Intellectual Product]

Phrase: "was"

Phrase: "loaded in the first lane"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1708639:Lane [Spatial Concept]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "from the left."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]
Processing 00000000.tx.131: E, similar effects on sAPP and A levels were seen in the conditioned media of LRP-ST cells that were transfected with a similar LRP-ST construct but lacking a Myc tag. 

Phrase: "E,"

Phrase: "similar effects on sAPP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "seen in the conditioned media of LRP-ST cells"
Meta Candidates (Total=26; Excluded=8; Pruned=0; Remaining=18)
   790   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   753   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   751   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   736   C0007634:Cells [Cell]
   736   C0009458:Media [Intellectual Product]
   736   C0009647:Conditioned [Mental Process]
   736   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0162867:Media [Tissue]
   736   C0205397:Seen [Qualitative Concept]
   736   C0439849:Related [Qualitative Concept]
   736   C0445223:Related [Finding]
   736   C1254021:Media [Tissue]
   736   C3272372:ST [Intellectual Product]
   736   C3282337:Cells [Cell]
   734   C1514760:Receptor Cell [Cell]
   703 E C0042789:see [Organism Function]
   703 E C0439536:Medium [Quantitative Concept]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1705217:Medium [Substance]
   703 E C1947903:See [Activity]
   703 E C1948049:Cell [Spatial Concept]
   703 E C3244283:medium [Intellectual Product]

Phrase: "that"

Phrase: "were"

Phrase: "transfected with a similar LRP-ST construct"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   806   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   775   C0386684:lipoprotein A receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   757   C0065058:Lipoprotein (a) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0125953:Lipoprotein (a-) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   757   C1096202:Lipoprotein-a [Laboratory Procedure]
   739   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C2348205:Similar [Qualitative Concept]
   739   C2827421:Construct [Classification]
   739   C3272372:ST [Intellectual Product]

Phrase: "but"

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "a Myc tag."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037293:Tag [Neoplastic Process]
   861   C0181496:Tag [Manufactured Object]
   861   C1710492:TAG [Gene or Genome]
Processing 00000000.tx.132: This shows that the effects are not secondary to the Myc sequences. 

Phrase: "This"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "not secondary to the Myc sequences."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0175668:Secondary to [Temporal Concept]
           Secondary
   753   C0027627:secondary [Neoplastic Process]
   753   C0205436:Secondary [Quantitative Concept]
Processing 00000000.tx.133: *, p < 0.05 compared with control APP-WT CHO cells.  

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with control APP-WT CHO cells."
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0085080:CHO Cells [Cell]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243148:control [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550141:Control [Substance]
   742   C1707455:Compared [Activity]
   742   C1709634:Precursor [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700323:WT [Fish]
   742   C3274648:Control [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.134: Reduction in Cell-surface APP by LRP-STTo test whether the increased sAPP, CTFs, and A levels in MycST cells were because of the increased stability of APP, we next examined the turnover of full-length APP by pulse-chase analysis in APP-WT CHO and MycST cells. 

Phrase: "Reduction in Cell-surface APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   845   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   845   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   845   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   829   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0011560:Amyloid [Pathologic Function]
   795   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1709634:Precursor [Idea or Concept]

Phrase: "by LRP-STTo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the increased sAPP,"

Phrase: "CTFs,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "A levels in MycST cells"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were because of the increased stability of APP,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C2350440:Protein Stability [Qualitative Concept]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205217:Increased [Quantitative Concept]
   739   C0205360:Stability [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1709634:Precursor [Idea or Concept]
   739   C2347098:Stability [Qualitative Concept]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the turnover of full-length APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597297:Protein Turnover [Molecular Function]
   744   C0031227:turnover [Quantitative Concept]
   744   C0243127:turnover [Functional Concept]
   744   C0443331:Turnover [Health Care Activity]

Phrase: "by pulse-chase analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "in APP-WT CHO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "and"

Phrase: "MycST cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: However, there was no change in the turnover rate of APP in MycST cells as compared with controls (t1/2, 60 min) (Fig. 5, A and B). 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "no change in the turnover rate of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442739:No change [Finding]
   760   C1548568:No change [Intellectual Product]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(t1/2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413227:T1 [Gene or Genome]

Phrase: "60 min) (Fig. 5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0349966:Fig [Food]
   812   C0702093:/min [Temporal Concept]
   812   C1337208:FIG [Food]

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.136: Similarly, the increase in CTF levels in MycST cells might also be due to its enhanced stability. 

Phrase: "Similarly,"

Phrase: "the increase in CTF levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "might"

Phrase: "also"

Phrase: "be due to its enhanced stability."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0205360:Stability [Qualitative Concept]
   753   C2347098:Stability [Qualitative Concept]
   753   C2349975:Enhanced [Activity]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]
Processing 00000000.tx.137: As with full-length APP, there was no significant difference in the half-life of APP CTFs (2 h) in MycST cells as compared with controls (Fig. 5C), suggesting that the increased APP CTF level in MycST cells is secondary to enhanced production. 

Phrase: "As with full-length APP,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443225:Full [Qualitative Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in the half-life"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "of APP CTFs"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   841   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragments [Functional Concept]
   799   C0486805:Fragments [Body Substance]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766 E C1708096:Fragment [Qualitative Concept]

Phrase: "(2 h) in MycST cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0011744:2 H [Element, Ion, or Isotope]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]

Phrase: "as"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 5C"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the increased APP CTF level in MycST cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0919677:Protein C level [Laboratory Procedure]
   751   C0428479:Protein level [Laboratory or Test Result]
   736   C0441889:Level [Qualitative Concept]
   736   C0456079:Level [Classification]
   736   C1547707:Level [Geographic Area]
   736   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "secondary to enhanced production."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]
Processing 00000000.tx.138: View larger version (14K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.140: Turnover of full-length APP and APP CTF, APP internalization and surface APP level in MycST cells. 

Phrase: "Turnover of full-length APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597297:Protein Turnover [Molecular Function]
   748   C0031227:turnover [Quantitative Concept]
   748   C0243127:turnover [Functional Concept]
   748   C0443331:Turnover [Health Care Activity]

Phrase: "and"

Phrase: "APP CTF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   858   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1168438:Protein C [Laboratory Procedure]
   827   C1418943:PROTEIN C [Gene or Genome]
   827   C1707271:C-Terminal [Amino Acid Sequence]
   827   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0205088:Terminal [Temporal Concept]
   799   C0332255:fragment [Functional Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "APP internalization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871786:internalization [Mental Process]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "surface APP level in MycST cells."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.141: There is no change in either APP maturation and turnover or APP CTF turnover in MycST cells as compared with APP-WT CHO cells. 

Phrase: "There"

Phrase: "is"

Phrase: "no change in either APP maturation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442739:No change [Finding]
   770   C1548568:No change [Intellectual Product]
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031227:turnover [Quantitative Concept]
  1000   C0243127:turnover [Functional Concept]
  1000   C0443331:Turnover [Health Care Activity]

Phrase: "or"

Phrase: "APP CTF turnover in MycST cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0597297:Protein Turnover [Molecular Function]
   739   C0031227:turnover [Quantitative Concept]
   739   C0243127:turnover [Functional Concept]
   739   C0443331:Turnover [Health Care Activity]

Phrase: "as"

Phrase: "compared with APP-WT CHO cells."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085080:CHO Cells [Cell]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1707455:Compared [Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C2700323:WT [Fish]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.142: Representative autoradiograph from pulse-chase experiments after metabolic labeling with [35S]methionine/cysteine is shown for APP (A) and quantitation of full-length APP and APP CTF turnover from three separate experiments expressed as mean  S.E. 

Phrase: "Representative autoradiograph from pulse-chase experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2986957:Autoradiograph [Manufactured Object]

Phrase: "after metabolic labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine/cysteine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "shown for APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "(A"

Phrase: ")"

Phrase: "and"

Phrase: "quantitation of full-length APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709793:Quantitation [Quantitative Concept]

Phrase: "and"

Phrase: "APP CTF turnover from three separate experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   754   C0597297:Protein Turnover [Molecular Function]
   738   C0031227:turnover [Quantitative Concept]
   738   C0243127:turnover [Functional Concept]
   738   C0443331:Turnover [Health Care Activity]

Phrase: "expressed as mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444504:Mean [Quantitative Concept]
   790   C2347634:Mean [Quantitative Concept]
   790   C2348143:Mean [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.143: (B and C, respectively). 

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "C,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.144: Steady-state internalization of APP from the cell surface (D) and the cell-surface APP levels (E) were measured with iodinated 1G7 antibody at 37 C and at 4 C, respectively, as described under "Experimental Procedures." 

Phrase: "Steady-state internalization of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0871786:internalization [Mental Process]

Phrase: "from the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "("

Phrase: "D)"

Phrase: "and"

Phrase: "the cell-surface APP levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0441889:Levels [Qualitative Concept]
   793   C0428479:Protein level [Laboratory or Test Result]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]

Phrase: "(E)"

Phrase: "were"

Phrase: "measured with iodinated 1G7 antibody"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "at 37 C"

Phrase: "and at 4 C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "respectively,"

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.145: The ratios of internalized to cell-surface APP and the surface APP levels in MycST cells are normalized to the APP-WT CHO cells. 

Phrase: "The ratios of"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0456603:Ratios [Quantitative Concept]
   790   C1610540:*Ratios [Quantitative Concept]
   756 E C1547037:Ratio [Intellectual Product]

Phrase: "internalized to cell-surface APP"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0699040:Cell surface [Cell Component]
   774   C0018956:precursor cell [Cell]
   774   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0007634:Cell [Cell]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205148:Surface [Spatial Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1709634:Precursor [Idea or Concept]
   748   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the surface APP levels in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0441889:Levels [Qualitative Concept]
   731   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "normalized to the APP-WT CHO cells."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0085080:CHO Cells [Cell]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]
   742   C1882115:Normalized [Research Activity]
   742   C2700323:WT [Fish]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.146: The APP internalization was comparable between the two cell lines. 

Phrase: "The APP internalization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871786:internalization [Mental Process]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "comparable between the two cell lines."
Processing 00000000.tx.147: However, there was 30% reduction in the cell-surface APP level in MycST cells. 

Phrase: "However,"

Phrase: "there"

Phrase: "was"

Phrase: "30% reduction in the cell-surface APP level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0301630:Reduction [Natural Phenomenon or Process]
   739   C0392756:Reduction [Qualitative Concept]
   739   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in MycST cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.148: *, p < 0.05; 

Phrase: "*,"

Phrase: "p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.149: **, p < 0.0001.  

Phrase: "*"

Phrase: "*,"

Phrase: "p < 0.0001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.150: In CHO cells, a major pathway for the generation and secretion of A appears to be derived from endocytic processing of APP from the cell surface (30, 31). 

Phrase: "In CHO cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "a major pathway for the generation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "secretion of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "derived from endocytic processing of APP"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0033666:protein processing [Molecular Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1441547:Derived [Qualitative Concept]
   744   C1709634:Precursor [Idea or Concept]
   744   C1709694:Processing [Activity]
   744   C3245521:derived [Idea or Concept]

Phrase: "from the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "(30,"

Phrase: "31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: Accordingly, we next measured the internalization of APP using an iodinated APP antibody (1G7). 

Phrase: "Accordingly,"

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the internalization of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871786:internalization [Mental Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an iodinated APP antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "(1G7"

Phrase: ")."
Processing 00000000.tx.152: The internalization of APP was expressed as a ratio between the 125I-1G7 antibody bound to intracellular and cell-surface APP. 

Phrase: "The internalization of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0871786:internalization [Mental Process]

Phrase: "was"

Phrase: "expressed as a ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]

Phrase: "between the 125I-1G7 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "bound to intracellular"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0175996:intracellular [Cell Component]
   790   C0178719:Intracellular [Spatial Concept]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "cell-surface APP."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.153: Although APP internalization was essentially unchanged (7% reduction, Fig. 5D), a 30% reduction in steady-state levels of cell-surface APP was observed in MycST cells as compared with control APP-WT CHO cells (Fig. 5E). 

Phrase: "Although"

Phrase: "APP internalization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871786:internalization [Mental Process]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "essentially unchanged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442739:Unchanged [Finding]
   861   C2346711:Unchanged [Qualitative Concept]

Phrase: "(7% reduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "Fig. 5D"

Phrase: ")"

Phrase: ","

Phrase: "a 30% reduction in steady-state levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of cell-surface APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "observed in MycST cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "compared with control APP-WT CHO cells"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0085080:CHO Cells [Cell]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243148:control [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550141:Control [Substance]
   742   C1707455:Compared [Activity]
   742   C1709634:Precursor [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700323:WT [Fish]
   742   C3274648:Control [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 5E"

Phrase: ")."
Processing 00000000.tx.154: These results suggested that LRP-ST altered the processing of APP in compartments prior to trafficking to the cell surface. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "the processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "in compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1185625:Compartments [Body Space or Junction]
  1000   C1382196:Compartments [Natural Phenomenon or Process]
   966 E C2986730:Compartment [Spatial Concept]

Phrase: "prior to"

Phrase: "trafficking to the cell surface."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C0599896:trafficking [Cell Function]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.155: Such a phenotype resembles that of the APP "Swedish mutation" where decreased cell-surface APP and increased -secretase cleavage products were documented (31, 32). 

Phrase: "Such"

Phrase: "a phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "resembles"

Phrase: "that of the APP ""Swedish mutation"" where"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
   742   C1709634:Precursor [Idea or Concept]
   742   C1710263:Swedish [Population Group]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "cell-surface APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "increased -"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "secretase cleavage products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.156: However, we failed to document any increase in either the protein or in the mRNA level of -secretase (data not shown). 

Phrase: "However,"

Phrase: "we"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "any increase in either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or in the mRNA level of -secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.157: The alterations in the level of cell-surface APP level as well as the changes in APP/A processing in MycST cells indicated that there may be perturbed trafficking of APP to different subcellular organelles. 

Phrase: "The alterations in the level of cell-surface APP level"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   703   C1515926:Alteration [Idea or Concept]

Phrase: "as well as"

Phrase: "the changes in APP/A processing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0025320:The change [Physiologic Function]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that there"

Phrase: "may"

Phrase: "be"

Phrase: "perturbed"

Phrase: "trafficking of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0599895:Protein Trafficking [Cell Function]
   797   C1159772:Protein Trafficking [Cell Function]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0599896:trafficking [Cell Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "to different subcellular organelles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0029219:Organelles [Cell Component]
Processing 00000000.tx.158: Therefore, we examined the subcellular localization of APP by immunolocalization and sucrose density gradient fractionation after sodium carbonate extraction or Triton X-100 solubilization. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the subcellular localization of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597704:protein localisation [Cell Function]
   774   C1159772:Protein Localization [Cell Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "by immunolocalization"

Phrase: "and"

Phrase: "sucrose density gradient fractionation after sodium carbonate extraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   800   C0007704:Fractionation, Density Gradient [Laboratory Procedure]
   744   C0016640:fractionation [Laboratory Procedure]
   744   C0524811:fractionation [Therapeutic or Preventive Procedure]
   744   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "Triton X-100 solubilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.159: However, we could not detect any significant changes in APP subcellular localization in MycST cells with either of these two approaches (data not shown). 

Phrase: "However,"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any significant changes in APP subcellular localization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "in MycST cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with either"

Phrase: "of these two approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: Effect of MycST Deletion Mutants on APP ProcessingA recent study using the yeast two-hybrid assay reported that the cytoplasmic tail of LRP could interact with several functionally distinct proteins, such as JIP1 and -2, PSD-95, and Mint2 (6). 

Phrase: "Effect of MycST Deletion Mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on APP ProcessingA recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557651:Study [Manufactured Object]
   799   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the yeast two-hybrid assay"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C1961118:Yeast Two-Hybrid Assay [Molecular Biology Research Technique]
   923   C0752172:Two-Hybrid Assay [Molecular Biology Research Technique]
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0243073:assay [Qualitative Concept]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the cytoplasmic tail of LRP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1511625:Cytoplasmic Tail [Cell Component]
   767   C0206587:Cytoplasmic Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C1333198:Cytoplasmic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0010834:Cytoplasmic [Cell Component]
   744   C0039259:Tail [Body Part, Organ, or Organ Component]
   744   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "could"

Phrase: "interact with several functionally distinct proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as JIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417024:JIP1 [Gene or Genome]

Phrase: "and -"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "PSD-95,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0900627:PSD-95 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1333226:PSD-95 [Gene or Genome]
  1000   C1705335:PSD-95 [Gene or Genome]
   861   C1418591:PSD [Gene or Genome]
   861   C1418984:PSD [Gene or Genome]

Phrase: "and"

Phrase: "Mint2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412457:MINT2 [Gene or Genome]
  1000   C3538727:MINT2 [Gene or Genome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.161: In addition, it has been shown that the NPXY domains of both LRP and APP cytoplasmic tails bind to adaptor proteins FE65, mDab, and Shc (57, 24, 26, 33). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the NPXY domains of both LRP"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   762   C0162808:Protein Domains [Spatial Concept]
   745 E C1514562:Protein Domain [Amino Acid Sequence]
   708   C1880389:Domain [Functional Concept]
   708   C1883221:Domain [Conceptual Entity]
   708   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "APP cytoplasmic tails"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1511625:Cytoplasmic Tail [Cell Component]
   804   C0010834:Cytoplasmic [Cell Component]
   804   C0039259:Tails [Body Part, Organ, or Organ Component]
   804   C0521449:Cytoplasmic [Body Location or Region]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "bind to adaptor proteins FE65,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1412459:FE65 [Gene or Genome]
   760   C1706710:Adaptor [Manufactured Object]

Phrase: "mDab,"

Phrase: "and"

Phrase: "Shc"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705297:SHC [Gene or Genome]

Phrase: "(57,"

Phrase: "24,"

Phrase: "26,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.162: Because FE65, Shc, and Mint proteins have been shown to differentially modulate A secretion (3337), it is possible that binding of the cytoplasmic adaptor proteins to the NPXY motifs of the LRP cytoplasmic tail region could account for the increased A secretion observed in MycST cells. 

Phrase: "Because"

Phrase: "FE65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "Shc,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705297:SHC [Gene or Genome]

Phrase: "and"

Phrase: "Mint proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(3337"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that binding of the cytoplasmic adaptor proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   774   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "to the NPXY motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "of the LRP cytoplasmic tail region"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   845   C1514562:Protein Region [Amino Acid Sequence]
   829   C1183489:Cytoplasmic region [Cell Component]
   795   C0017446:Region [Geographic Area]
   795   C0205147:Region [Spatial Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "could"

Phrase: "account for the increased A secretion"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "observed in MycST cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.163: Thus, we first expressed Myc-LRP-ST constructs lacking the first (Myc-LRP-ST NPTY) or second (Myc-LRP-ST NPVY) NPXY motifs in parental APP-WT CHO cells. 

Phrase: "Thus,"

Phrase: "we first expressed Myc-LRP-ST constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   758   C2827421:Construct [Classification]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "(Myc-LRP-ST NPTY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "(Myc-LRP-ST NPVY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: "NPXY motifs in parental APP-WT CHO cells."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   757   C0752190:Protein Motifs [Spatial Concept]
   741 E C1514562:Protein Motif [Amino Acid Sequence]
           Motif
Processing 00000000.tx.164: Surprisingly, expression of both Myc-LRP-ST deletion constructs still increased the levels of A as compared with control APP-WT CHO cells (Fig. 6A), indicating that neither NPXY core motif alone in LRP-ST is functional with respect to the increase in A production. 

Phrase: "Surprisingly,"

Phrase: "expression of both Myc-LRP-ST deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "still"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the levels of A"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "as"

Phrase: "compared with control APP-WT CHO cells"
Meta Candidates (Total=23; Excluded=3; Pruned=0; Remaining=20)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0085080:CHO Cells [Cell]
   762   C0018956:cells precursor [Cell]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cells [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243148:control [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1550141:Control [Substance]
   742   C1707455:Compared [Activity]
   742   C1709634:Precursor [Idea or Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C2700323:WT [Fish]
   742   C3274648:Control [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "neither NPXY core motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "alone in LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205171:Alone [Quantitative Concept]
   748   C0439044:alone [Finding]
   748   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "functional with respect to the increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205245:Functional [Functional Concept]
   753   C0542341:Functional [Functional Concept]
   753   C2700217:Functional [Conceptual Entity]

Phrase: "in A production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.165: Based on these results, we therefore hypothesized that regions flanking either one or both NPXY motifs must account for the increased A secretion by LRP-ST. 

Phrase: "Based on these results,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "we therefore"

Phrase: "hypothesized"

Phrase: "that regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "either one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "or"

Phrase: "both NPXY motifs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "must"

Phrase: "account for the increased A secretion"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1551359:account [Idea or Concept]
   753   C2741673:Account # [Clinical Attribute]
   753   C2981730:Account [Classification]

Phrase: "by LRP-ST."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.166: To test this possibility, additional mutant LRP-ST constructs were engineered. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "additional mutant LRP-ST constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "engineered."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]
Processing 00000000.tx.167: Although expression of the last 50 amino acid residues of LRP-ST (LRP-ST4897) still increased A secretion, expression of the first 47 amino acid residues of LRP-ST (LRP-ST147) had no effect on A secretion in APP-WT CHO cells (Fig. 6B). 

Phrase: "Although"

Phrase: "expression of the last 50 amino acid residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of LRP-ST (LRP-ST4897"

Phrase: ")"

Phrase: "still increased A secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "expression of the first 47 amino acid residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of LRP-ST (LRP-ST147"

Phrase: ")"

Phrase: "had"

Phrase: "no effect on A secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in APP-WT CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   859   C0018956:precursor cell [Cell]
   827   C0085080:CHO Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.168: These results suggest that amino acid residues in between positions 48 and 97 but not the core NPXY motif of LRP-ST (residues 57NFTNPVYATL66) are critical for the increased production of A following forced expression of the LRP cytosolic tail. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that amino acid residues in between positions 48"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   818   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   818   C2917660:Amino Acid [Pharmacologic Substance]
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]
   795   C0733755:positions [Spatial Concept]
   762   C1709915:Residue [Conceptual Entity]
   762   C1882936:RESIDUE [Phenomenon or Process]
   712 E C0240795:POSITIONAL [Finding]
   712 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the core NPXY motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514562:Motif [Amino Acid Sequence]

Phrase: "of LRP-ST (residues 57NFTNPVYATL66"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: "are"

Phrase: "critical for the increased production of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511545:Critical [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "forced expression of the LRP cytosolic tail."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.169: View larger version (28K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.170: 6. 

Phrase: "6."
Processing 00000000.tx.171: Reduced A level in conditioned media from APP-WT CHO cells stably expressing N-terminal 47 amino acids of LRP-soluble tail (LRP-ST147). 

Phrase: "Reduced A level in conditioned media"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "from APP-WT CHO cells stably"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   845   C0018956:precursor cell [Cell]
   818   C0085080:CHO Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "N-terminal 47 amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   907   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   840   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806 E C2917660:Amino Acid [Pharmacologic Substance]
   804   C0001128:Acids [Chemical]
   771 E C0202406:Acid [Laboratory Procedure]

Phrase: "of LRP-soluble tail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0039259:Tail [Body Part, Organ, or Organ Component]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "(LRP-ST147"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.172: Deletion of the first (Myc-LRP-STNPTY) or second (Myc-LRP-STNPVY) NPXY domain of LRP-ST had no effect on the elevation of A levels induced by LRP-ST construct as compared with APP-WT CHO cell level (A). 

Phrase: "Deletion of the first"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "(Myc-LRP-STNPTY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "or"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "(Myc-LRP-STNPVY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "NPXY domain of LRP-ST"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "had"

Phrase: "no effect on the elevation of A levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1301751:No effect [Qualitative Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "induced by LRP-ST construct"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205263:Induced [Functional Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C2827421:Construct [Classification]
   744   C3272372:ST [Intellectual Product]

Phrase: "as"

Phrase: "compared with APP-WT CHO cell level"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0085080:CHO cell [Cell]
   762   C0018956:precursor cell [Cell]
   762   C0428479:Protein level [Laboratory or Test Result]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0007634:Cell [Cell]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1269647:Cell [Cell]
   742   C1547707:Level [Geographic Area]
   742   C1704653:Cell [Medical Device]
   742   C1707455:Compared [Activity]
   742   C1709634:Precursor [Idea or Concept]
   742   C1948049:Cell [Spatial Concept]
   742   C2700323:WT [Fish]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.173: When APP-WT CHO cells were stably transfected with the construct in which the second half of LRP-ST was deleted (LRP-ST147), but not the proximal half (LRP-ST4897), A levels in conditioned media were restored to control levels (B). 

Phrase: "When"

Phrase: "APP-WT CHO cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   859   C0018956:precursor cell [Cell]
   827   C0085080:CHO Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with the construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827421:Construct [Classification]

Phrase: "in which"

Phrase: "the second half of LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C2825407:Half [Quantitative Concept]
   726   C0337505:Half Relation [Family Group]

Phrase: "was"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(LRP-ST147"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the proximal half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "(LRP-ST4897"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "A levels in conditioned media"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "restored"

Phrase: "to control levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0243148:control [Qualitative Concept]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.174: When the fatty acylation signal peptide of Fyn tyrosine kinase was appended to the N terminus of LRP-ST (FA-LRP-ST), most of the expressed FA-LRP-ST was found in the membrane fraction (E, middle panel). 

Phrase: "When"

Phrase: "the fatty acylation signal peptide of Fyn tyrosine kinase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0037081:Signal Peptide [Amino Acid Sequence]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "appended to the N terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C3242343:append [Temporal Concept]

Phrase: "of LRP-ST (FA-LRP-ST), most"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   807   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   799   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   787   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   787   C0439849:Related [Qualitative Concept]
   787   C0445223:Related [Finding]
   787   C3272372:ST [Intellectual Product]
   716 E C0080103:Relation [Family Group]
   716 E C0869014:Relations [Social Behavior]

Phrase: "of the expressed FA-LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C3272372:ST [Intellectual Product]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "found in the membrane fraction"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0025255:Membrane [Tissue]
   760   C0150312:Found [Quantitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1554103:Fraction [Idea or Concept]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0243095:Find [Finding]

Phrase: "(E,"

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.175: Prolonged exposure of the immunoblot revealed low levels of FA-LRP-ST fragment in the cytosolic fraction (E, bottom panel). 

Phrase: "Prolonged exposure of the immunoblot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   760   C0439590:Prolonged [Temporal Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "low levels of FA-LRP-ST fragment"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0748025:Low protein level [Finding]
   741   C0428479:Protein level [Laboratory or Test Result]
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the cytosolic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(E,"

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.176: The translocation of the LRP-ST fragment from cytosolic to membrane fraction caused a reduction in both secreted sAPP (C) and A levels (D). 

Phrase: "The translocation of the LRP-ST fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0599893:Protein translocation [Cell Function]
   739   C0040715:Translocation [Cell or Molecular Dysfunction]
   739   C2987521:Translocation [Activity]

Phrase: "from cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "to membrane fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a reduction in both secreted sAPP ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "D)."
Processing 00000000.tx.177: *, p < 0.001; 

Phrase: "*,"

Phrase: "p < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.178: , p < 0.05 compared with control APP-WT cells.  

Phrase: ", p < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with control APP-WT cells."
Meta Candidates (Total=22; Excluded=3; Pruned=0; Remaining=19)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243148:control [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1550141:Control [Substance]
   744   C1707455:Compared [Activity]
   744   C1709634:Precursor [Idea or Concept]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C2700323:WT [Fish]
   744   C3274648:Control [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.179: Effect of Translocation of the LRP-ST to the Membrane Fraction on APP ProcessingBecause LRP-ST is soluble, we infer that it modulates APP processing in the cytoplasm. 

Phrase: "Effect of Translocation of the LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "to the Membrane Fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "on APP ProcessingBecause LRP-ST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C3272372:ST [Intellectual Product]

Phrase: "is"

Phrase: "soluble,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "we"

Phrase: "infer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679201:Infer [Mental Process]

Phrase: "that"

Phrase: "it"

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "APP processing in the cytoplasm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]
Processing 00000000.tx.180: This notion predicts that translocation of LRP-ST to the membrane should attenuate or even abolish its effect on APP processing. 

Phrase: "This notion"

Phrase: "predicts"

Phrase: "that translocation of LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0599893:Protein translocation [Cell Function]
   744   C0040715:Translocation [Cell or Molecular Dysfunction]
   744   C2987521:Translocation [Activity]

Phrase: "to the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "should"

Phrase: "attenuate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "or"

Phrase: "even"

Phrase: "abolish"

Phrase: "its effect on APP processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.181: To test this hypothesis, we engineered a mutant LRP-ST construct (FA-LRP-ST), which contains the fatty acylation (i.e. myristoylation and palmitoylation) signal sequences of Fyn tyrosine kinase (25) in its N-terminal end (Fig. 1). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "a mutant LRP-ST construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C2827421:Construct [Classification]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "(FA-LRP-ST),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the fatty acylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596565:fatty acylation [Phenomenon or Process]
   861   C0001383:Acylation [Natural Phenomenon or Process]

Phrase: "(i.e. myristoylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0598434:myristoylation [Molecular Function]
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "and"

Phrase: "palmitoylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598435:Palmitoylation [Molecular Function]

Phrase: ")"

Phrase: "signal sequences of Fyn tyrosine kinase"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0037081:Signal Sequences [Amino Acid Sequence]
   753   C0162326:Sequences [Nucleotide Sequence]
   753   C1710082:Signal [Phenomenon or Process]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "(25"

Phrase: ")"

Phrase: "in its N-terminal end (Fig. 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0205088:Terminal [Temporal Concept]
   804   C0349966:Fig [Food]
   804   C0444930:End [Spatial Concept]
   804   C1337208:FIG [Food]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C2746065:End [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.182: When these signal sequences were added to the N terminus of green fluorescent protein, the resultant green fluorescent protein chimera became primarily membrane-bound, whereas green fluorescent protein alone was found essentially only in the soluble fraction (>90%) (25). 

Phrase: "When"

Phrase: "these signal sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
  1000   C0037081:Signal Sequences [Amino Acid Sequence]
   861   C0162326:Sequences [Nucleotide Sequence]
   861   C1710082:Signal [Phenomenon or Process]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "added to the N terminus of green fluorescent protein,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C0332583:Green [Qualitative Concept]
   742   C1524062:Added [Functional Concept]
   708 E C1883712:Add [Functional Concept]

Phrase: "the resultant green fluorescent protein chimera"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0008109:Chimera [Organism]
   804   C1262946:Chimaera [Fish]
   804   C1318484:Chimera [Disease or Syndrome]
   717   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "became"

Phrase: "primarily membrane-bound,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   827   C0025255:Membrane [Tissue]
   827   C0332297:bound [Spatial Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1145667:Bound [Activity]
   827   C1167622:Bound [Molecular Function]
   827   C1689898:% bound [Quantitative Concept]
   827   C1706182:Membrane [Manufactured Object]
   827   C2349209:Bound [Conceptual Entity]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "whereas"

Phrase: "green fluorescent protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0332583:Green [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "essentially only in the soluble fraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205171:Only [Quantitative Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]
   753   C1720467:Only [Intellectual Product]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]

Phrase: "("

Phrase: ">90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.183: As expected, the majority of FA-LRP-ST protein was membrane-associated when expressed in CHO cells with only a small amount recovered in the cytosolic fraction (<5%) (Fig. 6E, middle panel). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "the majority of FA-LRP-ST protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0680220:majority [Social Behavior]

Phrase: "was"

Phrase: "membrane-associated"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0025255:Membrane [Tissue]
   861   C0332281:Associated [Qualitative Concept]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   827 E C0750490:Associate [Idea or Concept]
   827 E C1706221:Associate [Professional or Occupational Group]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "when"

Phrase: "expressed in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0085080:CHO Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "with only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "recovered in the cytosolic fraction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0521108:recovered [Qualitative Concept]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1383501:Cytosolic [Cell Component]
   760   C1554103:Fraction [Idea or Concept]
   726 E C2004454:recover [Organism Function]

Phrase: "("

Phrase: "<5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 6E,"

Phrase: "middle panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.184: After prolonged exposure, the FA-LRP-ST could be observed in the cytoplasmic fraction (Fig. 6E, bottom panel). 

Phrase: "After prolonged exposure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0274281:Exposure, NOS [Injury or Poisoning]
   861   C0332157:Exposure [Clinical Attribute]
   861   C0439590:Prolonged [Temporal Concept]

Phrase: "the FA-LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "observed in the cytoplasmic fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0010834:Cytoplasmic [Cell Component]
   760   C0521449:Cytoplasmic [Body Location or Region]
   760   C1264633:Fraction [Quantitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 6E,"

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.185: Next, we measured total sAPP and A levels in conditioned media from FA-LRP-ST-expressing cells. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "total sAPP"

Phrase: "and"

Phrase: "A levels in conditioned media"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "from FA-LRP-ST-expressing cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.186: Interestingly, FA-LRP-ST-expressing cells secreted a significantly reduced level of total sAPP (Fig. 6C) and A (Fig. 6D) as compared with MycST cells. 

Phrase: "Interestingly,"

Phrase: "FA-LRP-ST-expressing cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   847   C1514760:Receptor Cell [Cell]
   793   C0007634:Cells [Cell]
   793   C3282337:Cells [Cell]
   760 E C1269647:Cell [Cell]
   760 E C1704653:Cell [Medical Device]
   760 E C1948049:Cell [Spatial Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "a significantly reduced level of total sAPP (Fig. 6C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 6D"

Phrase: ")"

Phrase: "as"

Phrase: "compared with MycST cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1707455:Compared [Activity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.187: Levels of sAPP and A were intermediate between MycST and control cells, a finding that we attribute to the residual amount of FA-LRP-ST present in cytoplasmic fraction (Fig. 6E, bottom panel). 

Phrase: "Levels of sAPP"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0441889:Levels [Qualitative Concept]
   756 E C0456079:Level [Classification]
   756 E C1547707:Level [Geographic Area]
   756 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "intermediate between MycST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205103:Intermediate [Spatial Concept]
   790   C1550465:intermediate [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "control cells,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "we"

Phrase: "attribute to the residual amount"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0449234:Attribute [Idea or Concept]
   760   C1265611:Amount [Quantitative Concept]
   760   C1609982:Residual [Qualitative Concept]
   760   C1704772:Attribute [Conceptual Entity]
   760   C1882133:Attribute [Qualitative Concept]

Phrase: "of FA-LRP-ST present"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0150312:Present [Quantitative Concept]
   795   C0449450:Present [Idea or Concept]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "in cytoplasmic fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 6E,"

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.188: Nevertheless, these results indicate that the subcellular localization of LRP-ST is important for its role in APP processing. 

Phrase: "Nevertheless,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the subcellular localization of LRP-ST"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "important for its role"

Phrase: "in APP processing."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.189: Effects of LRP-ST on APP Processing Do Not Require Endogenous LRP ExpressionAlthough we initially predicted that LRP-ST would block the APP/LRP interaction to lower A production, this outcome was not seen in the studies. 

Phrase: "Effects of LRP-ST"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP Processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "Do"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Require"

Phrase: "Endogenous LRP ExpressionAlthough"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "we initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "would"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the APP/LRP interaction to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   791   C1704675:Interaction [Functional Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "A production,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "this outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in the studies."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0205397:Seen [Qualitative Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0042789:see [Organism Function]
   737 E C0557651:Study [Manufactured Object]
   737 E C1947903:See [Activity]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.190: This indicated that LRP-ST may not be blocking the APPLRP complex. 

Phrase: "This"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the APPLRP complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.191: Accordingly, to test whether the perturbations in APP processing we observed are independent of LRP, the LRP-ST construct was expressed in the CHO 13-5-1 cell line that is deficient in LRP. 

Phrase: "Accordingly,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the perturbations in APP processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C0332453:perturbation [Functional Concept]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "are independent of LRP,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332291:Independent of [Functional Concept]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085862:Independent [Idea or Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1299583:Independent [Finding]
   748   C1551058:Are [Quantitative Concept]

Phrase: "the LRP-ST construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C2827421:Construct [Classification]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "expressed in the CHO 13-5-1 cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0007600:Cell Line [Cell]
   762   C0085080:CHO cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0205132:Line [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1550648:Line [Substance]
   742   C1552960:Line [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "is"

Phrase: "deficient in LRP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011155:Deficient [Functional Concept]
   753   C1636779:% deficient [Quantitative Concept]
   716   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.192: Surprisingly, both sAPP and A levels were indeed increased in 13-5-1 cells expressing Myc-LRP-ST, much like that seen in LRP-expressing APP-WT CHO cells (Fig. 7). 

Phrase: "Surprisingly,"

Phrase: "both sAPP"

Phrase: "and"

Phrase: "A levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "indeed"

Phrase: "increased in 13-5-1 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "Myc-LRP-ST,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "much like that"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "in LRP-expressing APP-WT CHO cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   863   C1514760:Receptor Cell [Cell]
   813   C0018956:precursor cell [Cell]
   801   C0085080:CHO Cells [Cell]
   788   C0007634:Cells [Cell]
   788   C3282337:Cells [Cell]
   755 E C1269647:Cell [Cell]
   755 E C1704653:Cell [Medical Device]
   755 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.193: Thus, these results are consistent with the hypothesis that the LRP-ST effect on APP processing is independent of endogenous LRP and therefore did not inhibit APP/LRP interaction as predicted. 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with the hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that"

Phrase: "the LRP-ST effect on APP processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1280500:Effect [Qualitative Concept]
   736   C2348382:Effect [Qualitative Concept]

Phrase: "is independent of endogenous LRP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0332291:Independent of [Functional Concept]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0085862:Independent [Idea or Concept]
   744   C0205227:Endogenous [Functional Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1299583:Independent [Finding]

Phrase: "and"

Phrase: "therefore"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "APP/LRP interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   869   C0872079:Protein-Protein Interaction [Molecular Function]
           protein interaction
   793   C1704675:Interaction [Functional Concept]

Phrase: "as"

Phrase: "predicted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.194: View larger version (24K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.195: 7. 

Phrase: "7."
Processing 00000000.tx.196: Effect of Myc-LRP-ST is independent of endogenous LRP expression. 

Phrase: "Effect of Myc-LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is independent of endogenous LRP expression."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   764   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0332291:Independent of [Functional Concept]
   764   C1171362:protein expression [Genetic Function]
   762   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   762   C0597360:receptor expression [Genetic Function]
   742   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0085862:Independent [Idea or Concept]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0205227:Endogenous [Functional Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1299583:Independent [Finding]
Processing 00000000.tx.197: Transfection of Myc-LRP-ST in LRP-deficient 13-5-1 CHO cells increased sAPP and A secretion similar to that seen in APP-WT CHO cells. 

Phrase: "Transfection of Myc-LRP-ST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "in LRP-deficient 13-5-1 CHO cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   863   C1514760:Receptor Cell [Cell]
   804   C0085080:CHO Cells [Cell]
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   707   C0757661:Lipoprotein Receptor-Related Protein 5 [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "sAPP"

Phrase: "and"

Phrase: "A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen in APP-WT CHO cells."
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085080:CHO Cells [Cell]
   767   C0018956:cells precursor [Cell]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0007634:Cells [Cell]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205397:Seen [Qualitative Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C2700323:WT [Fish]
   744   C3282337:Cells [Cell]
   711 E C0042789:see [Organism Function]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1947903:See [Activity]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.198: Comparable levels of full-length APP (FL-APP) are seen in the two 13-5-1 cell lines. 

Phrase: "Comparable levels of full-length APP (APP)"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "seen in the two 13-5-1 cell lines."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   764   C0007600:Cell lines [Cell]
   742   C0007634:Cell [Cell]
   742   C0205132:lines [Spatial Concept]
   742   C0205397:Seen [Qualitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   708 E C0042789:see [Organism Function]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]
   708 E C1947903:See [Activity]
Processing 00000000.tx.199: Immunoblots for FL-APP, sAPP, and A were performed using antibodies CT15, 1G7/5A3, and 26D6, respectively.  

Phrase: "Immunoblots for FL-APP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "sAPP,"

Phrase: "and"

Phrase: "A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies CT15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412189:CT15 [Gene or Genome]

Phrase: "1G7/5A3,"

Phrase: "and"

Phrase: "26D6,"

Phrase: "respectively."
Processing 00000000.tx.200: Myc-LRP-ST Expression Does Not Impair AICD/FE65-mediated TranscriptionRecently, it was reported that the expression of the cytoplasmic domain of LRP abolished the transcriptional activation mediated by the APP intracellular domain released after -secretase cleavage, AICD, and FE65 (8). 

Phrase: "Myc-LRP-ST Expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597360:receptor expression [Genetic Function]
   829   C1171362:protein expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "Does"

Phrase: "Not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Impair"

Phrase: "AICD/FE65-mediated TranscriptionRecently,"

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the expression of the cytoplasmic domain of LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C0597360:receptor expression [Genetic Function]
   754   C1171362:expression protein [Genetic Function]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "abolished"

Phrase: "the transcriptional activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0162493:Transcriptional Activation [Genetic Function]
   861   C1879547:Activation [Activity]

Phrase: "mediated by the APP intracellular domain"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0162808:Protein Domain [Spatial Concept]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C1514562:Protein Domain [Amino Acid Sequence]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0175996:intracellular [Cell Component]
   744   C0178719:Intracellular [Spatial Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "after -"

Phrase: "secretase cleavage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010813:cleavage [Cell Function]
   861   C0596311:Cleavage [Phenomenon or Process]
   861   C1330957:cleavage [Cell Function]

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.201: Therefore, we examined whether abnormal APP processing by Myc-LRP-ST expression is associated with changes in AICD/FE65-mediated transcription. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "abnormal APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0033666:protein processing [Molecular Function]
   804   C1709694:Processing [Activity]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0311448:Abnormal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "by Myc-LRP-ST expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597360:receptor expression [Genetic Function]
   829   C1171362:protein expression [Genetic Function]
   795   C0185117:Expression [Therapeutic or Preventive Procedure]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "is"

Phrase: "associated with changes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705241:Change [Quantitative Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in AICD/FE65-mediated transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.202: As expected, co-transfection of FE65 together with APP-Gal4 substantially increased the transactivation of the reporter, whereas FE65 was unable to augment the transactivation of the mutant APP lacking the NPXY domain (APP-Gal4) (Fig. 8). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "co-transfection of FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "together with APP-Gal4 substantially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1416832:GAL4 [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the transactivation of the reporter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040624:Transactivation [Genetic Function]

Phrase: "whereas"

Phrase: "FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "was"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "the transactivation of the mutant APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0040624:Transactivation [Genetic Function]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the NPXY domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "(APP-Gal4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1416832:GAL4 [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")"

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.203: However, co-transfection of Myc-LRP-ST had no effect on the transcriptional activation mediated by AICD/FE65 (Fig. 8). 

Phrase: "However,"

Phrase: "co-transfection of Myc-LRP-ST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "had"

Phrase: "no effect on the transcriptional activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "mediated by AICD/FE65"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0972395:aicd [Medical Device]
   770   C1412459:FE65 [Gene or Genome]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.204: Thus, these data indicate that transcriptional consequences associated with AICD/FE65 do not underlie the changes in abnormal APP processing seen by LRP-ST expression. 

Phrase: "Thus,"

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "that transcriptional consequences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]

Phrase: "associated with AICD/FE65"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0972395:aicd [Medical Device]
   770   C1412459:FE65 [Gene or Genome]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "underlie"

Phrase: "the changes in abnormal APP processing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   754   C0025320:The change [Physiologic Function]
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "seen by LRP-ST expression."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   767   C0597360:receptor expression [Genetic Function]
   767   C1171362:expression protein [Genetic Function]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205397:Seen [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C3272372:ST [Intellectual Product]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]
Processing 00000000.tx.205: View larger version (13K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(13K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.206: 8. 

Phrase: "8."
Processing 00000000.tx.207: Myc-LRP-ST does not inhibit AICD-mediated transcription in a heterologous reporter assay system. 

Phrase: "Myc-LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "AICD-mediated transcription in a heterologous reporter assay system."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.208: Co-expression of an APP-Gal4 fusion protein induced only minimal transactivation of the gene (luciferase). 

Phrase: "Co-expression of an APP-Gal4 fusion protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C1517332:Fusion Protein Expression [Cell or Molecular Dysfunction]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "only minimal transactivation of the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0040624:Transactivation [Genetic Function]

Phrase: "(luciferase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024075:Luciferase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: ")."
Processing 00000000.tx.209: Co-expression of FE65 and APP-Gal4 fusion protein strongly stimulated transcription of the Gal4-dependent reporter that was not attenuated by Myc-LRP-ST. 

Phrase: "Co-expression of FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "APP-Gal4 fusion protein strongly stimulated transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0040649:Transcription [Genetic Function]

Phrase: "of the Gal4-dependent reporter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0335038:Reporter [Professional or Occupational Group]
   827   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   827   C1705915:Reporter [Conceptual Entity]
   827   C1709908:Reporter [Group]

Phrase: "that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "attenuated by Myc-LRP-ST."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   767   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332161:Attenuated [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C0599946:Attenuated [Activity]
   744   C3272372:ST [Intellectual Product]
Processing 00000000.tx.210: No induction of reporter gene activity was seen by co-expression of FE65 with a mutant APP-Gal4 construct, where the NPTY motif was deleted (APP-Gal4). 

Phrase: "No induction of reporter gene activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0920532:gene induction [Genetic Function]
   783   C1621983:induction activity [Cell Function]
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "seen by co-expression of FE65"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205397:Seen [Qualitative Concept]
   753   C1412459:FE65 [Gene or Genome]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "with a mutant APP-Gal4 construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "where"

Phrase: "the NPTY motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]

Phrase: "was"

Phrase: "deleted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Deleted [Activity]

Phrase: "(APP-Gal4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1416832:GAL4 [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.211: The results are expressed as fold induction in transcription over control cells expressing the Gal4 DNA-binding domain alone.   

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as fold induction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205263:Induction [Functional Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "in transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "over control cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0007634:Cells [Cell]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the Gal4 DNA-binding domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C1511662:DNA Binding Domain [Amino Acid Sequence]
   861   C1148673:DNA Binding [Genetic Function]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.212: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Increasing evidence suggests that LRP has opposing effects on APP processing and A metabolism. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   758   C1514811:Reference [Idea or Concept]
   758   C1706462:Reference [Conceptual Entity]

Phrase: "Increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "opposing effects on APP processing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.213: On one hand, LRP mediates the clearance of A either by itself or following complex formation of A with various LRP ligands (1418). 

Phrase: "On one hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the clearance of A either"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "by itself"

Phrase: "or"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "complex formation of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "with various LRP ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   841   C1621296:receptor ligand [Molecular Function]
   799   C0023688:Ligands [Chemical]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "(1418"

Phrase: ")."
Processing 00000000.tx.214: On the other, LRP also influences multiple steps in APP processing to modulate A formation (2022). 

Phrase: "On the"

Phrase: "other,"

Phrase: "LRP also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "influences"

Phrase: "multiple steps in APP processing to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C1261552:steps [Conceptual Entity]
   711 E C1704379:Step [Functional Concept]
   711 E C1705117:Step [Quantitative Concept]
   711 E C2825408:Step [Manufactured Object]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(2022"

Phrase: ")."
Processing 00000000.tx.215: The latter appears to involve an interaction between LRP and APP that is mediated by FE65 as an adaptor molecule linking the respective cytosolic domains to form a functional tripartite complex (24). 

Phrase: "The latter"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "an interaction between LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0872079:interaction protein [Molecular Function]
   748   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "that"

Phrase: "is"

Phrase: "mediated by FE65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   790   C1412459:FE65 [Gene or Genome]

Phrase: "as an adaptor molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "linking"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "the respective cytosolic domains to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C1511625:Cytosolic Domain [Cell Component]
   779   C1880389:Domain [Functional Concept]
   779   C1883221:Domain [Conceptual Entity]
   779   C3541951:Domain [Intellectual Product]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a functional tripartite complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.216: To further investigate the mechanism by which LRP modulates A generation, we hypothesized that expression of the LRP cytosolic domain, LRP-ST, should interfere with the APPLRP complex and in so doing, perturb normal APP processing to inhibit A generation. 

Phrase: "To further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the mechanism by which LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0441712:Mechanism [Functional Concept]
   744   C1706376:Mechanism [Manufactured Object]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that expression of the LRP cytosolic domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0597360:receptor expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "LRP-ST,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "should"

Phrase: "interfere with the APPLRP complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439855:Complex [Qualitative Concept]
   760   C0521102:Interfere [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and in so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "doing"

Phrase: ","

Phrase: "perturb"

Phrase: "normal APP processing to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033666:protein processing [Molecular Function]
   799   C1709694:Processing [Activity]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "A generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.217: To our surprise, expression of LRP-ST in CHO cells not only did not impair A generation, we found that A generation was paradoxically increased. 

Phrase: "To our surprise,"

Phrase: "expression of LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0597360:receptor expression [Genetic Function]
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in CHO cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0085080:CHO Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impair"

Phrase: "A generation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that A generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0079411:Generation [Temporal Concept]
   861   C3146294:Generation [Activity]
   768 E C1414672:Genesis [Gene or Genome]
   768 E C2984892:Genesis [Gene or Genome]

Phrase: "was"

Phrase: "paradoxically"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.218: Like LRP-deficient cells, sAPP secretion was enhanced by LRP-ST expression, but unlike the LRP deficiency state, this change was due primarily to a preferential increase in sAPP secretion (21). 

Phrase: "Like LRP-deficient cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   859   C1514760:Receptor Cell [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "sAPP secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "enhanced by LRP-ST expression,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   770   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   767   C0597360:receptor expression [Genetic Function]
   767   C1171362:expression protein [Genetic Function]
   744   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C2349975:Enhanced [Activity]
   744   C3272372:ST [Intellectual Product]

Phrase: "but unlike the LRP deficiency state,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   818   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   764   C0033626:Protein Deficiency [Disease or Syndrome]
   764   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   764   C0162429:Deficiency state [Disease or Syndrome]
           Deficiency
   762   C0020623:Lipoprotein deficiency [Disease or Syndrome]
   762   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   742   C0011155:Deficiency [Functional Concept]
   742   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0233535:but [Mental or Behavioral Dysfunction]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C1623416:deficiency [Qualitative Concept]
   742   C3148680:State [Geographic Area]

Phrase: "this change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "due primarily to a preferential increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0678226:Due to [Functional Concept]
           due
   753   C0442805:Increase [Functional Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "in sAPP secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.219: Although endocytic APP is often correlated with A generation in non-neural cells, LRP-ST expression did not alter APP internalization (20). 

Phrase: "Although"

Phrase: "endocytic APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "correlated with A generation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0011560:Amyloid [Pathologic Function]
   770   C0079411:Generation [Temporal Concept]
   770   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1707520:Correlated [Qualitative Concept]
   770   C3146294:Generation [Activity]

Phrase: "in non-neural cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C0027882:Neural cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "LRP-ST expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   876   C0597360:receptor expression [Genetic Function]
   839   C1171362:protein expression [Genetic Function]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "APP internalization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0871786:internalization [Mental Process]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.220: These results taken together suggested that cytosolic LRP-ST facilitates the trafficking and processing of APP through a pathway resembling that of the Swedish APP mutation, where A-, sAPP-, and -cleaved APP C-terminal fragment levels are selectively augmented. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cytosolic LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "facilitates"

Phrase: "the"

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0033666:protein processing [Molecular Function]
   760   C1709694:Processing [Activity]

Phrase: "through a pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "resembling"

Phrase: "that of the Swedish APP mutation,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]
   744   C1709634:Precursor [Idea or Concept]
   744   C1710263:Swedish [Population Group]

Phrase: "where A-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "sAPP-,"

Phrase: "and -"

Phrase: "cleaved APP C-terminal fragment levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   839   C0919677:Protein C level [Laboratory Procedure]
   834   C0428479:Protein level [Laboratory or Test Result]
   793   C0441889:Levels [Qualitative Concept]
   760 E C0456079:Level [Classification]
   760 E C1547707:Level [Geographic Area]
   760 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "selectively"

Phrase: "augmented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]
Processing 00000000.tx.221: Further, because increased BACE-mediated cleavage of APP takes place in the trans-Golgi network, there is reduced full-length APP at the cell surface (31, 32), a finding common to both cells expressing APP Swedish mutation and the LRP-ST. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "because"

Phrase: "increased BACE-mediated cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597304:Protein Cleavage [Molecular Function]
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in the trans-Golgi network,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0442504:Place [Spatial Concept]
   753   C1704765:Place [Functional Concept]
   753   C1882509:Place [Activity]
   753   C3496241:place [Disease or Syndrome]

Phrase: "there"

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "full-length APP at the cell surface"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0018956:precursor cell [Cell]
   762   C0025252:protein surface [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "a finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "common to both cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "expressing"

Phrase: "APP Swedish mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "and"

Phrase: "the LRP-ST."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.222: The mechanism by which LRP-ST expression increased APP processing through the -secretase (BACE) pathway is unclear. 

Phrase: "The mechanism by which LRP-ST expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0441712:Mechanism [Functional Concept]
   739   C1706376:Mechanism [Manufactured Object]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "APP processing through the -secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0033666:protein processing [Molecular Function]
   748   C1709694:Processing [Activity]

Phrase: "(BACE) pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.223: The fact that similar results were seen when LRP-ST was expressed in LRP-expressing and LRP-deficient CHO cells indicated that this effect is independent of LRP. 

Phrase: "The fact"

Phrase: "that similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "when"

Phrase: "LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "expressed in LRP-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "expressing"

Phrase: "and"

Phrase: "LRP-deficient CHO cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   860   C1514760:Receptor Cell [Cell]
   818   C0085080:CHO Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is independent of LRP."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332291:Independent of [Functional Concept]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085862:Independent [Idea or Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1299583:Independent [Finding]
Processing 00000000.tx.224: In other words, LRP-ST likely did not interfere with the LRPAPP complex. 

Phrase: "In other words,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   966   C1705313:Word [Idea or Concept]
   928 E C0439824:Verbal [Qualitative Concept]
   900 E C0871946:verb [Intellectual Product]

Phrase: "LRP-ST likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with the LRPAPP complex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439855:Complex [Qualitative Concept]
   760   C0521102:Interfere [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.225: However, in addition to FE65 and LRP, a number of other cytosolic proteins are known to interact with APP including X11/Mint (3436, 38, 39) and its isoforms (X11L and X11L2) (34, 40), JNK-interacting proteins (JIP1b and JIP2) (41) and mDab (7, 42, 43). 

Phrase: "However,"

Phrase: "in addition to FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "a number of other cytosolic proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interact with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "X11/Mint"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0452249:Mint [Food]
   861   C0522467:Mint [Plant]
   861   C1337213:mint [Food]
   861   C1576800:MINT [Organic Chemical,Pharmacologic Substance]

Phrase: "(3436,"

Phrase: "38,"

Phrase: "39"

Phrase: ")"

Phrase: "and"

Phrase: "its isoforms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(X11L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412457:X11L [Gene or Genome]
  1000   C3538727:X11L [Gene or Genome]

Phrase: "and"

Phrase: "X11L2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412458:X11L2 [Gene or Genome]
  1000   C3538728:X11L2 [Gene or Genome]

Phrase: ")"

Phrase: "(34,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "JNK-interacting proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   988   C1422725:JNK interacting protein [Gene or Genome]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(JIP1b"

Phrase: "and"

Phrase: "JIP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417025:JIP2 [Gene or Genome]

Phrase: ")"

Phrase: "(41"

Phrase: ")"

Phrase: "and"

Phrase: "mDab"

Phrase: "(7,"

Phrase: "42,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.226: These studies suggested that interactions between the GYENPTY motif of APP and the phosphotyrosine-binding/protein interaction (PTB/PI) domains of some of these adaptor proteins can modulate A secretion (34, 36, 41). 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that interactions between the GYENPTY motif of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1956035:Protein Interaction Motif [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0872079:interactions protein [Molecular Function]
   706   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the phosphotyrosine-binding/protein interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0872079:protein interaction [Molecular Function]
   812   C1704675:Interaction [Functional Concept]

Phrase: "(PTB/PI) domains of some of these adaptor proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   745   C0162808:Protein Domains [Spatial Concept]
   745   C1518827:PTB Domain [Amino Acid Sequence]
   728 E C1514562:Protein Domain [Amino Acid Sequence]
   708   C1880389:Domain [Functional Concept]
   708   C1883221:Domain [Conceptual Entity]
   708   C3541951:Domain [Intellectual Product]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(34,"

Phrase: "36,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.227: Because LRP also binds to JIP-1, mDab, and FE65 probably through its distal NPXY motif (6, 7, 24), it is possible that LRP-ST might effectively compete with APP for binding to adaptor proteins to influence A secretion. 

Phrase: "Because"

Phrase: "LRP also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to JIP-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1417024:JIP-1 [Gene or Genome]
   770   C0345893:JIP [Neoplastic Process]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "mDab,"

Phrase: "and"

Phrase: "FE65 probably through its distal NPXY motif"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1412459:FE65 [Gene or Genome]

Phrase: "(6,"

Phrase: "7,"

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "might"

Phrase: "effectively"

Phrase: "compete with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "for binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to adaptor proteins to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "influence"

Phrase: "A secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.228: In our study, expression of the distal half of LRP-ST (LRP-ST4897 fragment) containing the distal NPXY domain, but not the proximal half (LRP-ST147 fragment), increased A secretion (Fig. 6). 

Phrase: "In our study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "expression of the distal half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of LRP-ST (LRP-ST4897 fragment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   860   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   788   C0332255:fragment [Functional Concept]
   788   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the distal NPXY domain,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the proximal half"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2825407:Half [Quantitative Concept]

Phrase: "(LRP-ST147 fragment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "increased A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.229: This suggests that the sequestration of adaptor proteins (e.g. JIP-1b, mDab, and FE65) by LRP-ST might account for this phenotype. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the sequestration of adaptor proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443301:Sequestration [Functional Concept]

Phrase: "("

Phrase: "e.g. JIP-1b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "mDab,"

Phrase: "and"

Phrase: "FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: ")"

Phrase: "by LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "might"

Phrase: "account for this phenotype."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]
   770   C1551359:account [Idea or Concept]
   770   C2741673:Account # [Clinical Attribute]
   770   C2981730:Account [Classification]
Processing 00000000.tx.230: However, removal of the second NPVY motif alone (Myc-LRP-ST NPVY) was not sufficient to abrogate the effects of LRP-ST on A secretion, indicating that LRP-ST was interfering with other unknown target molecules that interact with additional sequences beyond the NPVY motif. 

Phrase: "However,"

Phrase: "removal of the second NPVY motif"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Myc-LRP-ST NPVY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "not sufficient to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205410:Sufficient [Qualitative Concept]
   827   C1518422:Not [Functional Concept]

Phrase: "abrogate"

Phrase: "the effects of LRP-ST"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on A secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "indicating"

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "interfering with other unknown target molecules"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C3242252:unknown target [Intellectual Product]
   753   C0439673:Unknown [Qualitative Concept]
   753   C0521102:interfering [Qualitative Concept]
   753   C0567416:molecules [Substance]
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]
   742   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]

Phrase: "that"

Phrase: "interact with additional sequences"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0162326:Sequences [Nucleotide Sequence]
   770   C1524062:Additional [Functional Concept]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "beyond the NPVY motif."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.231: These findings led us to postulate that LRP-ST may either facilitate the trafficking of APP to compartments containing BACE or enhance BACE-mediated cleavage of APP. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "led"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1708698:LED [Manufactured Object]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C1522538:Lead [Functional Concept]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "postulate"

Phrase: "that LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "may"

Phrase: "either"

Phrase: "facilitate"

Phrase: "the"

Phrase: "trafficking of APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0599895:Protein Trafficking [Cell Function]
   797   C1159772:Protein Trafficking [Cell Function]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0599896:trafficking [Cell Function]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "to compartments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1185625:Compartments [Body Space or Junction]
  1000   C1382196:Compartments [Natural Phenomenon or Process]
   966 E C2986730:Compartment [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "or"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "BACE-mediated cleavage of APP."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]
Processing 00000000.tx.232: The latter scenario is consistent with the recent observations that phosphorylation of APP on Thr-668 changes the conformation of APP cytoplasmic tail to influence the interaction with FE65 as well as to alter A secretion (33). 

Phrase: "The latter scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683579:scenario [Functional Concept]

Phrase: "is"

Phrase: "consistent with the recent observations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that phosphorylation of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   753   C0031715:Phosphorylation [Molecular Function]

Phrase: "on Thr-668"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040005:Thr [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "the conformation of APP cytoplasmic tail to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0033625:Protein Conformation [Spatial Concept]
   742   C0026377:Conformation [Spatial Concept]

Phrase: "influence"

Phrase: "the interaction with FE65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "as well as"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "A secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.233: Another potential explanation for our findings is that the effect is mediated at the level of nuclear transcription. 

Phrase: "Another potential explanation for our findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "mediated at the level of nuclear transcription."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0040649:Transcription [Genetic Function]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C0521447:Nuclear [Spatial Concept]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.234: LRP was recently shown to be a -secretase substrate, and this cleavage event (S3) releases a C-terminal fragment (LRP-ICD) analogous to the Notch intracellular domain NICD. 

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a -secretase substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "and"

Phrase: "this cleavage event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "(S3)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1179706:S3 [Body Location or Region]
  1000   C1335643:S3 [Gene or Genome]
  1000   C1419033:S3 [Gene or Genome]

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "a C-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(LRP-ICD) analogous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "to the Notch intracellular domain NICD."
Processing 00000000.tx.235: Furthermore, Kinoshita et al. 

Phrase: "Furthermore,"

Phrase: "Kinoshita et al."
Processing 00000000.tx.236: (8) reported that the last 105 amino acids of LRP -chain (LRP105) inhibited transcriptional activity of the AICD, FE65, and Tip60 complex in a heterologous signaling system, presumably by interfering with the interaction between AICD and Tip60. 

Phrase: "(8"

Phrase: ")"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the last 105 amino acids of LRP -chain"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C1874187:acids amino protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   755   C0051610:Receptor, Amino Acid [Amino Acid, Peptide, or Protein,Receptor]
   738   C0001128:Acids [Chemical]
   722 E C2917660:Amino Acid [Pharmacologic Substance]
   704 E C0202406:Acid [Laboratory Procedure]

Phrase: "(LRP105"

Phrase: ")"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "transcriptional activity of the AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "FE65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412459:FE65 [Gene or Genome]

Phrase: "and"

Phrase: "Tip60 complex in a heterologous signaling system,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "presumably by"

Phrase: "interfering with the interaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0521102:interfering [Qualitative Concept]
   770   C1704675:Interaction [Functional Concept]

Phrase: "between AICD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "and"

Phrase: "Tip60."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333931:TIP60 [Gene or Genome]
  1000   C1336632:TIP60 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1705504:TIP60 [Gene or Genome]
Processing 00000000.tx.237: However, the latter activity of LRP105 does not explain how LRP-ST affects APP processing, because co-transfection of Myc-LRP-ST had no effect on the transcriptional activation mediated by AICD/FE65 (Fig. 8). 

Phrase: "However,"

Phrase: "the latter activity of LRP105"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "how LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP processing,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "because"

Phrase: "co-transfection of Myc-LRP-ST"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "had"

Phrase: "no effect on the transcriptional activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "mediated by AICD/FE65"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C0972395:aicd [Medical Device]
   770   C1412459:FE65 [Gene or Genome]
   770   C2611803:AICD [Cell Function]
   770   C3156099:AICD [Cell Function]
   770   C3537205:AICD [Cell Function]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.238: The lack of effect in AICD-mediated transactivation by Myc-LRP-ST was not unexpected, because, unlike LRP105, LRP-ST did not show any nuclear localization (data not shown). 

Phrase: "The lack of effect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in AICD-mediated transactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040624:Transactivation [Genetic Function]

Phrase: "by Myc-LRP-ST"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C3272372:ST [Intellectual Product]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C0919474:MYC Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not unexpected,"

Phrase: "because"

Phrase: ","

Phrase: "unlike LRP105,"

Phrase: "LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any nuclear localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.239: The addition of a signal peptide sequence to LRP105 displaced LRP105 out of the nucleus with the resultant loss of its inhibitory effect on AICD-mediated transactivation (8). 

Phrase: "The addition of a signal peptide sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "to LRP105"

Phrase: "displaced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012727:Displaced [Spatial Concept]

Phrase: "LRP105 out of the nucleus"

Phrase: "with the resultant loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "of its inhibitory effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "on AICD-mediated transactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040624:Transactivation [Genetic Function]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.240: This suggested that nuclear localization of LRP intracellular domain (LRP-ICD) is required to influence AICD-mediated gene transcription activity. 

Phrase: "This"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that nuclear localization of LRP intracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0597704:protein localisation [Cell Function]
   757   C1159772:Protein Localization [Cell Function]
   757   C1660749:intracellular localization [Cell Function]
   739   C0475264:Localisation [Functional Concept]
   739   C1744691:localisation [Biologic Function]

Phrase: "(LRP-ICD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "AICD-mediated gene transcription activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.241: In addition, because LRP105 is 8 amino acid residues (VVFWYKRR) longer and exhibits different subcellular localization than LRP-ST, it is likely that LRP105 and LRP-ST are not functionally equivalent. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "because"

Phrase: "LRP105"

Phrase: "is"

Phrase: "8 amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(VVFWYKRR"

Phrase: ")"

Phrase: "longer"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]
   916 E C1444754:Length [Quantitative Concept]
   916 E C1706316:LENGTH [Research Activity]

Phrase: "and"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "different subcellular localization than LRP-ST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0597704:protein localisation [Cell Function]
   762   C1159772:Protein Localization [Cell Function]
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that LRP105"

Phrase: "and"

Phrase: "LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "are"

Phrase: "not functionally equivalent."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205163:Equivalent [Qualitative Concept]
   827   C0439185:equivalent [Quantitative Concept]
Processing 00000000.tx.242: Although both LRP105 and LRP-ST are engineered based on the earlier study which showed a release of the LRP-ICD by the presenilin-dependent mechanism (9), the exact nature of LRP-ICD remains to be clarified. 

Phrase: "Although"

Phrase: "both LRP105"

Phrase: "and"

Phrase: "LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C3272372:ST [Intellectual Product]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "are"

Phrase: "engineered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878517:engineered [Professional or Occupational Group]

Phrase: "based on the earlier study"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0557651:Study [Manufactured Object]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2603343:Study [Research Activity]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726   C1279919:Early [Temporal Concept]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a release of the LRP-ICD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "by the presenilin-dependent mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "the exact nature of LRP-ICD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0349590:Nature [Idea or Concept]
   742   C1262865:Nature [Functional Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clarified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]
Processing 00000000.tx.243: Of note, the cellular localization LRP-ST appears to play an important role in APP processing. 

Phrase: "Of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the cellular localization LRP-ST"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C3272372:ST [Intellectual Product]
   710   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in APP processing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.244: When the FA signal peptide was added to LRP-ST to translocate LRP-ST to the membrane, much of the effect of LRP-ST on APP processing was lost (Fig. 6, C and D). 

Phrase: "When"

Phrase: "the FA signal peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0037081:Signal Peptide [Amino Acid Sequence]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "added to LRP-ST"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C1524062:Added [Functional Concept]
   748   C3272372:ST [Intellectual Product]
   714 E C1883712:Add [Functional Concept]

Phrase: "to"

Phrase: "translocate"

Phrase: "LRP-ST to the membrane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3272372:ST [Intellectual Product]

Phrase: "much of the effect of LRP-ST"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   760   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   757   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   739   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0439849:Related [Qualitative Concept]
   739   C0445223:Related [Finding]
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]
   739   C3272372:ST [Intellectual Product]

Phrase: "on APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.245: In summary, our study provided additional evidence for the role of LRP in APP processing and specifically demonstrated that the soluble form of LRP cytoplasmic tail (LRP-ST) alone can modulate the processing of APP and secretion of A. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "additional evidence for the role of LRP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "specifically"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the soluble form of LRP cytoplasmic tail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "(LRP-ST) alone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0205171:Alone [Quantitative Concept]
   799   C0439044:alone [Finding]
   799   C0679994:alone [Group Attribute]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0033666:protein processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "secretion of A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0036536:secretion [Biologic Function]
   790   C0036537:Secretion [Body Substance]
Processing 00000000.tx.246: These effects associated with LRP-ST may provide an additional tool for elucidating a mechanism by which APP is guided to the amyloidogenic instead of non-amyloidogenic pathway.  

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "associated with LRP-ST"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C3272372:ST [Intellectual Product]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an additional tool for elucidating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0336791:Tool [Manufactured Object]
   760   C2827396:Tool [Manufactured Object]

Phrase: "a mechanism by which APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "guided to the amyloidogenic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0181090:Guide [Professional or Occupational Group]
   737   C0302614:Guide [Medical Device]
   737   C1706050:Guide [Manufactured Object]

Phrase: "instead of non-amyloidogenic pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.247: FOOTNOTES  * This work was supported in part by National Institutes of Health Grant AG12376 (to E. H. K.). 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by National Institutes of Health Grant AG12376"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0027468:National Institutes of Health [Health Care Related Organization]

Phrase: "("

Phrase: "to E. H. K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.248: Present address: Dept. of Molecular Neurodegeneration, Institute for Physiological Chemistry and Pathobiochemistry, University of Mainz, 55099 Mainz, Germany.  

Phrase: "Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Molecular Neurodegeneration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "Institute for Physiological Chemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Pathobiochemistry,"

Phrase: "University of Mainz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "55099 Mainz,"

Phrase: "Germany."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]
Processing 00000000.tx.249: To whom correspondence should be addressed: Dept. of Neurosciences, University of California, San Diego, 9500 Gilman Dr., Mail Code 0691, La Jolla, CA 92093-0691. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Dept."

Phrase: "of Neurosciences,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0027910:Neurosciences [Biomedical Occupation or Discipline]
   966 E C1552241:Neuroscience [Professional or Occupational Group]
   966 E C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "9500 Gilman Dr., Mail Code 0691,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C0009219:code [Occupational Activity]
   799   C0024492:Mail [Manufactured Object]
   799   C0031831:DR [Professional or Occupational Group]
   799   C0805701:Code [Intellectual Product]
   799   C1538057:MAIL [Gene or Genome]
   799   C1547565:Mail [Idea or Concept]
   799   C1707664:DR [Biomedical or Dental Material]
   799   C2348314:Dr. [Conceptual Entity]
   799   C3540849:DR [Idea or Concept]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92093-0691."
Processing 00000000.tx.250: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.251: 858-822-1024; 

Phrase: "858-822-1024"

Phrase: ";"
Processing 00000000.tx.252: Fax: 858-822-1021; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "858-822-1021"

Phrase: ";"
Processing 00000000.tx.253: E-mail: edkoo{at}ucsd.edu . 1 The abbreviations used are: LRP, low density lipoprotein receptor-related protein; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "edkoo{at}ucsd.edu . 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.254: APP, amyloid precursor protein; 

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.255: A, amyloid ; sAPP, soluble form of APP; 

Phrase: "A,"

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; sAPP,"

Phrase: "soluble form of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: ";"
Processing 00000000.tx.256: CTF, C-terminal fragment; 

Phrase: "CTF,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "C-terminal fragment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C0332255:fragment [Functional Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.257: ICD, intracellular domain; 

Phrase: "ICD,"

Phrase: "intracellular domain"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0175996:intracellular [Cell Component]
   861   C0178719:Intracellular [Spatial Concept]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.258: AICD, APP intracellular domain; 

Phrase: "AICD,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0972395:aicd [Medical Device]
  1000   C2611803:AICD [Cell Function]
  1000   C3156099:AICD [Cell Function]
  1000   C3537205:AICD [Cell Function]

Phrase: "APP intracellular domain"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   804   C0175996:intracellular [Cell Component]
   804   C0178719:Intracellular [Spatial Concept]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.259: ST, soluble tail; 

Phrase: "ST,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]

Phrase: "soluble tail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039259:Tail [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.260: FA, fatty acylated; 

Phrase: "FA,"

Phrase: "fatty acylated"

Phrase: ";"
Processing 00000000.tx.261: CHO cell, Chinese hamster ovary; 

Phrase: "CHO cell,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085080:CHO cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Chinese hamster ovary"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018555:Chinese Hamster [Mammal]
   827   C0008120:chinese [Language]
   827   C0018557:Hamster [Mammal]
   827   C0029939:Ovary [Body Part, Organ, or Organ Component]
   827   C0152035:Chinese [Population Group]
   827   C0227898:ovary [Body Part, Organ, or Organ Component]
   827   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: ";"
Processing 00000000.tx.262: WT, wild type; 

Phrase: "WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.263: apoE, apolipoprotein E; 

Phrase: "apoE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.264: BACE, -site APP-cleaving enzyme (or -secretase); 

Phrase: "BACE, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "site APP-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(or -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.265: JNK, c-Jun N-terminal kinase.  

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-Jun N-terminal kinase."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.266: ACKNOWLEDGMENTS  We thank Dr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.267: Thomas Sudhof for the gift of the AICD reporter plasmids, Dr. 

Phrase: "Thomas Sudhof for the gift of the AICD reporter plasmids,"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.268: Mark Lawson for assistance with luciferase assays, Drs. 

Phrase: "Mark Lawson for assistance"

Phrase: "with luciferase assays,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "Drs."
Processing 00000000.tx.269: Peter Sims, Sascha Weggen, Markus Kummer, and Sarah Sagi for helpful discussions, and Tracy Busse and Hiroko Maruyama for technical assistance.  

Phrase: "Peter Sims,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1420068:SIM [Gene or Genome]

Phrase: "Sascha Weggen,"

Phrase: "Markus Kummer,"

Phrase: "and"

Phrase: "Sarah Sagi for helpful discussions,"

Phrase: "and"

Phrase: "Tracy Busse"

Phrase: "and"

Phrase: "Hiroko Maruyama for technical assistance."
Processing 00000000.tx.270: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Herz, J., and Strickland, D. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J.,"

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.271: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.272: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.273: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.274: Investig. 

Phrase: "Investig."
Processing 00000000.tx.275: 108, 779784[Free FullText] Strickland, D. 

Phrase: "108,"

Phrase: "779784"

Phrase: "[Free FullText"

Phrase: "] Strickland,"

Phrase: "D."
Processing 00000000.tx.276: K., and Ranganathan, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ranganathan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.277: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.278: Thromb. 

Phrase: "Thromb."
Processing 00000000.tx.279: Haemost. 

Phrase: "Haemost."
Processing 00000000.tx.280: 1, 16631670[CrossRef][Medline] [OrderarticleviaInfotrieve] Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., and Stanley, K. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "16631670"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J.,"

Phrase: "Hamann,"

Phrase: "U.,"

Phrase: "Rogne,"

Phrase: "S."

Phrase: ","

Phrase: "Myklebost,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Gausepohl,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Stanley,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.281: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.282: (1988) EMBO J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.283: 7, 41194127[Abstract] Willnow, T. 

Phrase: "7,"

Phrase: "41194127"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Willnow,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.284: E., Moehring, J. 

Phrase: "E.,"

Phrase: "Moehring,"

Phrase: "J."
Processing 00000000.tx.285: M., Inocencio, N. 

Phrase: "M."

Phrase: ","

Phrase: "Inocencio,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.286: M., Moehring, T. 

Phrase: "M."

Phrase: ","

Phrase: "Moehring,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.287: J., and Herz, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.288: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.289: J. 

Phrase: "J."
Processing 00000000.tx.290: 313, 7176[Medline] [OrderarticleviaInfotrieve] Barnes, H., Ackermann, E. 

Phrase: "313,"

Phrase: "7176"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Barnes,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ackermann,"

Phrase: "E."
Processing 00000000.tx.291: J., and van der Geer, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "van der Geer,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.292: (2003) Oncogene 22, 35893597[CrossRef][Medline] [OrderarticleviaInfotrieve] Gotthardt, M., Trommsdorff, M., Nevitt, M. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Oncogene 22,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "35893597"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Gotthardt,"

Phrase: "M."

Phrase: ","

Phrase: "Trommsdorff,"

Phrase: "M."

Phrase: ","

Phrase: "Nevitt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.293: F., Shelton, J., Richardson, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shelton,"

Phrase: "J.,"

Phrase: "Richardson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443048:Richardson [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.294: A., Stockinger, W., Nimpf, J., and Herz, J. 

Phrase: "A.,"

Phrase: "Stockinger,"

Phrase: "W.,"

Phrase: "Nimpf,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.295: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.296: Biol. 

Phrase: "Biol."
Processing 00000000.tx.297: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.298: 275, 2561625624[Abstract/Free FullText] Trommsdorff, R., Borg, J. 

Phrase: "275,"

Phrase: "2561625624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Trommsdorff,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Borg,"

Phrase: "J."
Processing 00000000.tx.299: P., Margolis, B., and Herz, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Margolis,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.300: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.301: Biol. 

Phrase: "Biol."
Processing 00000000.tx.302: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.303: 273, 3355633560[Abstract/Free FullText] Kinoshita, A., Shah, T., Tangredi, M. 

Phrase: "273,"

Phrase: "3355633560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kinoshita,"

Phrase: "A.,"

Phrase: "Shah,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tangredi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.304: M., Strickland, D. 

Phrase: "M."

Phrase: ","

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.305: K., and Hyman, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.306: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.307: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.308: Biol. 

Phrase: "Biol."
Processing 00000000.tx.309: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.310: 278, 4118241188[Abstract/Free FullText] May, P., Reddy, Y. 

Phrase: "278,"

Phrase: "4118241188"

Phrase: "[Abstract/Free FullText"

Phrase: "] May,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Reddy,"

Phrase: "Y."
Processing 00000000.tx.311: K., and Herz, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J."
Processing 00000000.tx.312: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.313: Biol. 

Phrase: "Biol."
Processing 00000000.tx.314: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.315: 277, 1873618743[Abstract/Free FullText] Blacker, D., Wilcox, M. 

Phrase: "277,"

Phrase: "1873618743"

Phrase: "[Abstract/Free FullText"

Phrase: "] Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.316: A., Laird, N. 

Phrase: "A.,"

Phrase: "Laird,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.317: M., Rodes, L., Horvath, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Horvath,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.318: M., Go, R. 

Phrase: "M."

Phrase: ","

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.319: C., Perry, R., Watson, B., Bassett, S. 

Phrase: "C., Perry,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bassett,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.320: S., McInnis, M. 

Phrase: "S."

Phrase: ","

Phrase: "McInnis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: G., Albert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Albert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.322: S., Hyman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.323: T., and Tanzi, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.324: E. 

Phrase: "E."
Processing 00000000.tx.325: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.326: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.327: 19, 357360[CrossRef][Medline] [OrderarticleviaInfotrieve] Goate, A., Chartierharlin, M. 

Phrase: "19,"

Phrase: "357360"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Goate,"

Phrase: "A.,"

Phrase: "Chartierharlin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.328: C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., Mant, R., Newton, P., Rooke, K., Roques, P., Talbot, C., Pericakvance, M., Roses, A., Williamson, R., Rossor, M., Owen, M., and Hardy, J. 

Phrase: "C., Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mant,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rooke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pericakvance,"

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Williamson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Owen,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.329: (1991) Nature 349, 704706[CrossRef][Medline] [OrderarticleviaInfotrieve] Kang, D. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "704706"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kang,"

Phrase: "D."
Processing 00000000.tx.330: E., Saitoh, T., Chen, X., Xia, Y., Masliah, E., Hansen, L. 

Phrase: "E.,"

Phrase: "Saitoh,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "X.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Hansen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.331: A., Thomas, R. 

Phrase: "A.,"

Phrase: "Thomas,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.332: G., Thal, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Thal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039736:THAL [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.333: J., and Katzman, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Katzman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.334: (1997) Neurology 49, 5661[Abstract] Schmechel, D. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Neurology 49,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "5661"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Schmechel,"

Phrase: "D."
Processing 00000000.tx.335: E., Saunders, A. 

Phrase: "E.,"

Phrase: "Saunders,"

Phrase: "A."
Processing 00000000.tx.336: M., Strittmatter, W. 

Phrase: "M."

Phrase: ","

Phrase: "Strittmatter,"

Phrase: "W."
Processing 00000000.tx.337: J., Crain, B. 

Phrase: "J.,"

Phrase: "Crain,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.338: J., Hulette, C. 

Phrase: "J.,"

Phrase: "Hulette,"

Phrase: "C."
Processing 00000000.tx.339: M., Joo, S. 

Phrase: "M."

Phrase: ","

Phrase: "Joo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.340: H., Pericakvance, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Pericakvance,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: A., Goldgaber, D., and Roses, A. 

Phrase: "A.,"

Phrase: "Goldgaber,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.342: D. 

Phrase: "D."
Processing 00000000.tx.343: (1993) Proc. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.344: Natl. 

Phrase: "Natl."
Processing 00000000.tx.345: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.346: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.347: U. 

Phrase: "U."
Processing 00000000.tx.348: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.349: A. 

Phrase: "A."
Processing 00000000.tx.350: 90, 96499653[Abstract/Free FullText] Kang, D. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "96499653"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang,"

Phrase: "D."
Processing 00000000.tx.351: E., Pietrzik, C. 

Phrase: "E.,"

Phrase: "Pietrzik,"

Phrase: "C."
Processing 00000000.tx.352: U., Baum, L., Chevallier, N., Merriam, D. 

Phrase: "U.,"

Phrase: "Baum,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chevallier,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Merriam,"

Phrase: "D."
Processing 00000000.tx.353: E., Kounnas, M. 

Phrase: "E.,"

Phrase: "Kounnas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.354: Z., Wagner, S. 

Phrase: "Z.,"

Phrase: "Wagner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.355: L., Troncoso, J. 

Phrase: "L., Troncoso,"

Phrase: "J."
Processing 00000000.tx.356: C., Kawas, C. 

Phrase: "C., Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521083:Kawas [Plant]

Phrase: "C."
Processing 00000000.tx.357: H., Katzman, R., and Koo, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.358: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.359: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.360: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.361: Investig. 

Phrase: "Investig."
Processing 00000000.tx.362: 106, 11591166[Abstract/Free FullText] Narita, M., Holtzman, D. 

Phrase: "106,"

Phrase: "11591166"

Phrase: "[Abstract/Free FullText"

Phrase: "] Narita,"

Phrase: "M."

Phrase: ","

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.363: M., Schwartz, A. 

Phrase: "M."

Phrase: ","

Phrase: "Schwartz,"

Phrase: "A."
Processing 00000000.tx.364: L., and Bu, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.365: J. 

Phrase: "J."
Processing 00000000.tx.366: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.367: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.368: 69, 19041911[Medline] [OrderarticleviaInfotrieve] Qiu, Z. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "19041911"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Qiu,"

Phrase: "Z."
Processing 00000000.tx.369: H., Strickland, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.370: K., Hyman, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.371: T., and Rebeck, G. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.372: W. 

Phrase: "W."
Processing 00000000.tx.373: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.374: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.375: 73, 13931398[CrossRef][Medline] [OrderarticleviaInfotrieve] Shibata, M., Yamada, S., Kumar, S. 

Phrase: "73,"

Phrase: "13931398"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Shibata,"

Phrase: "M."

Phrase: ","

Phrase: "Yamada,"

Phrase: "S."

Phrase: ","

Phrase: "Kumar,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: R., Calero, M., Bading, J., Frangione, B., Holtzman, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Bading,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.377: M., Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.378: A., Strickland, D. 

Phrase: "A.,"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.379: K., Ghiso, J., and Zlokovic, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.380: V. 

Phrase: "V."
Processing 00000000.tx.381: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.382: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.383: Investig. 

Phrase: "Investig."
Processing 00000000.tx.384: 106, 14891499[Abstract/Free FullText] Deane, R., Wu, Z. 

Phrase: "106,"

Phrase: "14891499"

Phrase: "[Abstract/Free FullText"

Phrase: "] Deane,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Z."
Processing 00000000.tx.385: H., Sagare, A., Davis, J., Yan, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sagare,"

Phrase: "A.,"

Phrase: "Davis,"

Phrase: "J.,"

Phrase: "Yan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.386: D., Hamm, K., Xu, F., Parisi, M., Larue, B., Hu, H. 

Phrase: "D."

Phrase: ","

Phrase: "Hamm,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Xu,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Parisi,"

Phrase: "M."

Phrase: ","

Phrase: "Larue,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.387: W., Spijkers, P., Guo, H., Song, X. 

Phrase: "W., Spijkers,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Guo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "X."
Processing 00000000.tx.388: M., Lenting, P. 

Phrase: "M."

Phrase: ","

Phrase: "Lenting,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.389: J., Van Nostrand, W. 

Phrase: "J.,"

Phrase: "Van Nostrand,"

Phrase: "W."
Processing 00000000.tx.390: E., and Zlokovic, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.391: V. 

Phrase: "V."
Processing 00000000.tx.392: (2004) Neuron 43, 333344[CrossRef][Medline] [OrderarticleviaInfotrieve] Kounnas, M. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Neuron 43,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "333344"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kounnas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.393: Z., Moir, R. 

Phrase: "Z.,"

Phrase: "Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.394: D., Rebeck, G. 

Phrase: "D."

Phrase: ","

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.395: W., Bush, A. 

Phrase: "W., Bush,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0330099:Bush [Plant]

Phrase: "A."
Processing 00000000.tx.396: I., Argraves, W. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Argraves,"

Phrase: "W."
Processing 00000000.tx.397: S., Tanzi, R. 

Phrase: "S."

Phrase: ","

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.398: E., Hyman, B. 

Phrase: "E.,"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.399: T., and Strickland, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.400: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.401: (1995) Cell 82, 331340[CrossRef][Medline] [OrderarticleviaInfotrieve] Pietrzik, C. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cell 82,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "331340"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pietrzik,"

Phrase: "C."
Processing 00000000.tx.402: U., Busse, T., Merriam, D. 

Phrase: "U.,"

Phrase: "Busse,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Merriam,"

Phrase: "D."
Processing 00000000.tx.403: E., Weggen, S., and Koo, E. 

Phrase: "E.,"

Phrase: "Weggen,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.404: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.405: (2002) EMBO J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.406: 21, 56915700[Abstract/Free FullText] Ulery, P. 

Phrase: "21,"

Phrase: "56915700"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ulery,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.407: G., Beers, J., Mikhailenko, I., Tanzi, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beers [Food]

Phrase: "J.,"

Phrase: "Mikhailenko,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.408: E., Rebeck, G. 

Phrase: "E.,"

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.409: W., Hyman, B. 

Phrase: "W., Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.410: T., and Strickland, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.411: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.412: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.413: Biol. 

Phrase: "Biol."
Processing 00000000.tx.414: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.415: 275, 74107415[Abstract/Free FullText] Zerbinatti, C. 

Phrase: "275,"

Phrase: "74107415"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zerbinatti,"

Phrase: "C."
Processing 00000000.tx.416: V., Wozniak, D. 

Phrase: "V., Wozniak,"

Phrase: "D."
Processing 00000000.tx.417: F., Cirrito, J., Cam, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cirrito,"

Phrase: "J.,"

Phrase: "Cam,"

Phrase: "J."
Processing 00000000.tx.418: A., Osaka, H., Bales, K. 

Phrase: "A.,"

Phrase: "Osaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.419: R., Zhuo, M., Paul, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zhuo,"

Phrase: "M."

Phrase: ","

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: M., Holtzman, D. 

Phrase: "M."

Phrase: ","

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.421: M., and Bu, G. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.422: J. 

Phrase: "J."
Processing 00000000.tx.423: (2004) Proc. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.424: Natl. 

Phrase: "Natl."
Processing 00000000.tx.425: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.426: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.427: U. 

Phrase: "U."
Processing 00000000.tx.428: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.429: A. 

Phrase: "A."
Processing 00000000.tx.430: 101, 10751080[Abstract/Free FullText] Rebeck, G. 

Phrase: "101,"

Phrase: "10751080"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.431: W., Moir, R. 

Phrase: "W., Moir,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.432: D., Mui, S., Strickland, D. 

Phrase: "D."

Phrase: ","

Phrase: "Mui,"

Phrase: "S."

Phrase: ","

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.433: K., Tanzi, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.434: E., and Hyman, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.435: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.436: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.437: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.438: 87, 238245[Medline] [OrderarticleviaInfotrieve] Pietrzik, C. 

Phrase: "87,"

Phrase: "238245"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pietrzik,"

Phrase: "C."
Processing 00000000.tx.439: U., Yoon, I. 

Phrase: "U.,"

Phrase: "Yoon,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.440: S., Jaeger, S., Busse, T., Weggen, S., and Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Jaeger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325865:Jaeger [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Busse,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Weggen,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.441: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.442: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.443: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.444: 24, 42594265[Abstract/Free FullText] McCabe, J. 

Phrase: "24,"

Phrase: "42594265"

Phrase: "[Abstract/Free FullText"

Phrase: "] McCabe,"

Phrase: "J."
Processing 00000000.tx.445: B., and Berthiaume, L. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Berthiaume,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.446: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.447: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.448: Biol. 

Phrase: "Biol."
Processing 00000000.tx.449: Cell 10, 37713786[Abstract/Free FullText] Cao, X. 

Phrase: "Cell 10,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "37713786"

Phrase: "[Abstract/Free FullText"

Phrase: "] Cao,"

Phrase: "X."
Processing 00000000.tx.450: W., and Sudhof, T. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Sudhof,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.451: C. 

Phrase: "C."
Processing 00000000.tx.452: (2001) Science 293, 115120[Abstract/Free FullText] Emi, N., Friedmann, T., and Yee, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "115120"

Phrase: "[Abstract/Free FullText"

Phrase: "] Emi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880489:EMI [Phenomenon or Process]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Friedmann,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Yee,"

Phrase: "J."
Processing 00000000.tx.453: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.454: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.455: Virol. 

Phrase: "Virol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0965991:virol [Lipid]
Processing 00000000.tx.456: 65, 12021207[Medline] [OrderarticleviaInfotrieve] Koo, E. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "12021207"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Koo,"

Phrase: "E."
Processing 00000000.tx.457: H., Squazzo, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Squazzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.458: L., Selkoe, D. 

Phrase: "L., Selkoe,"

Phrase: "D."
Processing 00000000.tx.459: J., and Koo, C. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Koo,"

Phrase: "C."
Processing 00000000.tx.460: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.461: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.462: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.463: 109, 991998[Abstract/Free FullText] Sisodia, S. 

Phrase: "109,"

Phrase: "991998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.464: S., Koo, E. 

Phrase: "S."

Phrase: ","

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.465: H., Hoffman, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hoffman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.466: N., Perry, G., and Price, D. 

Phrase: "N., Perry,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.467: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.468: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.469: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.470: 13, 31363142[Abstract] Koo, E. 

Phrase: "13,"

Phrase: "31363142"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Koo,"

Phrase: "E."
Processing 00000000.tx.471: H., and Squazzo, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Squazzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.472: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.474: Biol. 

Phrase: "Biol."
Processing 00000000.tx.475: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.476: 269, 1738617389[Abstract/Free FullText] Perez, R. 

Phrase: "269,"

Phrase: "1738617389"

Phrase: "[Abstract/Free FullText"

Phrase: "] Perez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.477: G., Squazzo, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Squazzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.478: L., and Koo, E. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.479: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.480: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.481: Biol. 

Phrase: "Biol."
Processing 00000000.tx.482: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.483: 271, 91009107[Abstract/Free FullText] Thinakaran, G., Teplow, D. 

Phrase: "271,"

Phrase: "91009107"

Phrase: "[Abstract/Free FullText"

Phrase: "] Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.484: B., Siman, R., Greenberg, B., and Sisodia, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Siman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Greenberg,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.485: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.486: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.487: Biol. 

Phrase: "Biol."
Processing 00000000.tx.488: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.489: 271, 93909397[Abstract/Free FullText] Ando, K., Iijima, K., Elliott, J. 

Phrase: "271,"

Phrase: "93909397"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ando,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iijima,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Elliott,"

Phrase: "J."
Processing 00000000.tx.490: I., Kirino, Y., and Suzuki, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.491: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.492: Biol. 

Phrase: "Biol."
Processing 00000000.tx.493: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.494: 276, 4035340361[Abstract/Free FullText] Borg, J. 

Phrase: "276,"

Phrase: "4035340361"

Phrase: "[Abstract/Free FullText"

Phrase: "] Borg,"

Phrase: "J."
Processing 00000000.tx.495: P., Yang, Y. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y."
Processing 00000000.tx.496: N., Taddeo-Borg, M., Margolis, B., and Turner, R. 

Phrase: "N., Taddeo-Borg,"

Phrase: "M."

Phrase: ","

Phrase: "Margolis,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.497: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.498: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.499: Biol. 

Phrase: "Biol."
Processing 00000000.tx.500: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.501: 273, 1476114766[Abstract/Free FullText] Ho, C. 

Phrase: "273,"

Phrase: "1476114766"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.502: S., Marinescu, V., Steinhilb, M. 

Phrase: "S."

Phrase: ","

Phrase: "Marinescu,"

Phrase: "V.,"

Phrase: "Steinhilb,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.503: L., Gaut, J. 

Phrase: "L., Gaut,"

Phrase: "J."
Processing 00000000.tx.504: R., Turner, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.505: S., and Stuenkel, E. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stuenkel,"

Phrase: "E."
Processing 00000000.tx.506: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.507: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.510: 277, 2702127028[Abstract/Free FullText] Mueller, H. 

Phrase: "277,"

Phrase: "2702127028"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mueller,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.511: T., Borg, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Borg,"

Phrase: "J."
Processing 00000000.tx.512: P., Margolis, B., and Turner, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Margolis,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.513: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.515: Biol. 

Phrase: "Biol."
Processing 00000000.tx.516: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.517: 275, 3930239306[Abstract/Free FullText] Sabo, S. 

Phrase: "275,"

Phrase: "3930239306"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sabo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.518: L., Lanier, L. 

Phrase: "L., Lanier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.519: M., Ikin, A. 

Phrase: "M."

Phrase: ","

Phrase: "Ikin,"

Phrase: "A."
Processing 00000000.tx.520: F., Khorkova, O., Sahasrabudhe, S., Greengard, P., and Buxbaum, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Khorkova,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Sahasrabudhe,"

Phrase: "S."

Phrase: ","

Phrase: "Greengard,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Buxbaum,"

Phrase: "J."
Processing 00000000.tx.521: D. 

Phrase: "D."
Processing 00000000.tx.522: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.523: Biol. 

Phrase: "Biol."
Processing 00000000.tx.524: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.525: 274, 79527957[Abstract/Free FullText] Borg, J. 

Phrase: "274,"

Phrase: "79527957"

Phrase: "[Abstract/Free FullText"

Phrase: "] Borg,"

Phrase: "J."
Processing 00000000.tx.526: P., Ooi, J., Levy, E., and Margolis, B. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ooi,"

Phrase: "J.,"

Phrase: "Levy,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Margolis,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.527: (1996) Mol. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.528: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.529: Biol. 

Phrase: "Biol."
Processing 00000000.tx.530: 16, 62296241[Abstract] King, G. 

Phrase: "16,"

Phrase: "62296241"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] King,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.531: D., Perez, R. 

Phrase: "D."

Phrase: ","

Phrase: "Perez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: G., Steinhilb, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Steinhilb,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: L., Gaut, J. 

Phrase: "L., Gaut,"

Phrase: "J."
Processing 00000000.tx.534: R., and Turner, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Turner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.535: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.536: (2003) Neuroscience 120, 143154[CrossRef][Medline] [OrderarticleviaInfotrieve] Tanahashi, H., and Tabira, T. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuroscience 120,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: "143154"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tanahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Tabira,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.537: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.538: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.539: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.540: Commun. 

Phrase: "Commun."
Processing 00000000.tx.541: 258, 385389[CrossRef][Medline] [OrderarticleviaInfotrieve] Taru, H., Kirino, Y., and Suzuki, T. 

Phrase: "258,"

Phrase: "385389"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Taru,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kirino,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.542: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.543: Biol. 

Phrase: "Biol."
Processing 00000000.tx.544: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.545: 277, 2756727574[Abstract/Free FullText] Homayouni, R., Rice, D. 

Phrase: "277,"

Phrase: "2756727574"

Phrase: "[Abstract/Free FullText"

Phrase: "] Homayouni,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "D."
Processing 00000000.tx.546: S., Sheldon, M., and Curran, T. 

Phrase: "S."

Phrase: ","

Phrase: "Sheldon,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Curran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.547: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.548: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.549: 19, 75077515[Abstract/Free FullText] Howell, B. 

Phrase: "19,"

Phrase: "75077515"

Phrase: "[Abstract/Free FullText"

Phrase: "] Howell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.550: W., Lanier, L. 

Phrase: "W., Lanier,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.551: M., Frank, R., Gertler, F. 

Phrase: "M."

Phrase: ","

Phrase: "Frank,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gertler,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.552: B., and Cooper, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.553: A. 

Phrase: "A."
Processing 00000000.tx.554: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.555: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.556: Biol. 

Phrase: "Biol."
Processing 00000000.tx.557: 19, 51795188[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 280/20/20140 most recent M413729200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Yoon, I.-S. 

Phrase: "19,"

Phrase: "51795188"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/20/20140 most recent M413729200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Yoon,"

Phrase: "I.-S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.558: Articles by Koo, E. 

Phrase: "Articles by Koo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.559: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.560: Articles citing this Article PubMed PubMed Citation Articles by Yoon, I.-S. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Yoon,"

Phrase: "I.-S."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.561: Articles by Koo, E. 

Phrase: "Articles by Koo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.562: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.563: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

